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Down the rabbit hole 
This thesis is the result of my journey into the world of antimicrobial resistance (AMR). 
This journey started in 2017 with a collaboration between philosophers, microbiologists and 
infectious disease specialists working on a project about AMR screening of refugees in the 
Netherlands. After having finished a master’s in the humanities and social sciences, I joined 
this project for five months to analyse ethical aspects of such screenings. However, I stayed 
longer and became part of a team working on transdisciplinary approaches to AMR. I started 
studying different practices and meanings of AMR, and I travelled through three different 
settings: 1) international policies on AMR, 2) AMR healthcare practices 3) and microbiological 
and social science research on AMR. Starting this journey, I did not have a clear map that 
would guide me through these different settings; therefore, like Alice in Wonderland I went 
down the rabbit-hole ‘never once considering how in the world [I] was to get out again’. In the 
following thesis, I will lead you through the Wonderland that I discovered during this 
adventure. 
Biology in society and vice versa 
Antimicrobial resistance can be understood as both a biological and social phenomenon. 
As I travelled through the world of microbiology I learned that microbiologists define AMR as 
an evolutionary ability of microorganisms, including bacteria, viruses and parasites, to adapt 
to antimicrobials, such as antibiotics and antivirals (WHO, 2018). This ability of 
microorganisms challenges the treatment of infectious diseases and complicates medical 
procedures that require immunosuppression, such as chemotherapy or surgery (Martinez, 
2014). Such explanation of AMR in microbiology has not always been understood as an 
established fact – it has been developed only within the last 70 years. 
The first effective antimicrobial agents, sulfonamides, were introduced in 1937, and by the 
end of the 1930s bacteriologists had already announced that bacteria had developed resistant 
mechanisms to this agent (Davies & Davies, 2010). Similar developments have been recorded 
with other antibiotics introduced to the market: penicillin was first given to a patient in 1941, 
and in 1942 penicillin-resistant bacteria were identified (for a further chronology of AMR 
development see Figure 1). One of the first disciplines interested in the effects of antibiotics 
on bacteria was genetic science that analysed bacterial mutation processes that led to the 
development of resistant mechanisms (Landecker, 2015). In the 1940s and 1950s, these 
mutation processes were believed to be rare events limited to vertical genetic inheritance, 





end of the 1950s and beginning of the 1960s, 
the understanding of AMR and its 
mechanisms had begun to change.  
The rise of genetic engineering in the 
1960s led to a different vision of AMR: 
resistant genes can be transferred not only 
within the same bacterial population but also 
between different populations of bacteria 
(Landecker, 2015). This paradigmatic shift 
took place in biological sciences with the 
introduction of horizontal gene transfer – the 
transmission of genetic information both 
between and within different bacterial 
populations (Barlow, 2009). Subsequent 
microbiological research on multidrug-
resistant infections argued that bacteria could 
acquire resistance to antibiotics that they 
were previously exposed to. In addition, it 
was argued that bacteria might acquire 
resistant mechanisms from the environment 
and other bacteria, even if they had not had 
previous direct exposure to antibiotics 
(Levy, 2002). 
Since then the phenomenon of AMR 
has been linked to more and more mechanisms that bacteria can develop, including limiting 
the uptake of a drug, drug inactivation and drug efflux (Martinez, 2014; Reygaert, 2008). 
Although microbiology has generated substantial knowledge about the biological life of 
bacteria and their mechanisms of resistance, many authors stress that this knowledge is 
incomplete and constantly changing (Cox & Wright, 2013; Martinez, 2014; Reygaert, 2008). 
This brief history of biological inquiries into AMR shows that this phenomenon is not 
understood as something static or fixed but that it is a broad term that refers to different and 
constantly changing knowledge about bacteria. 
Travelling through the world of microbiology and learning about the biological 
mechanisms of AMR, I then returned to my home discipline of social science and philosophy. 
Figure 1: The timeline of the introduction of 
antibiotics and the appearance of antibiotic 
resistance (the figure is taken from Malmir 





There, I looked at the work of social scientists to understand how AMR can be studied as a 
social phenomenon. Social science scholars have studied various antibiotic practices in 
humans, animals and agriculture as well as practices of pharmaceutical and clinical waste 
management – namely, human practices that influence the acquisition of resistance by bacteria 
(Broom et al., 2014; Larsson, 2014; Rodrigues, 2020; Rutgersson et al., 2014). Apart from that, 
social scientists have reflected upon and conceptualised human-bacteria relations and their role 
in economic and political processes at the national and international levels (Brown & Nettleton, 
2016; Chandler, 2019; Landecker, 2015). These studies have shown that the practices of 
antibiotic use are influenced by different processes, including economic and structural 
accessibility of non-antibiotic treatments, the possibility to take time off work to recover from 
illness and economic pressures of market demands on farmers to produce more food. 
Therefore, similar to the microbiological understanding of AMR, social science studies have 
shown that this phenomenon refers to multiple social practices and processes that may 
influence the bacterial acquisition of resistance. 
The biological and social understandings of AMR can be brought together to create an 
umbrella biosocial concept of AMR that refers to multiple microorganisms and mechanisms to 
resist antimicrobials and to multiple social practices and processes that influence resistant 
mechanisms of bacteria.  
The management practices of this biosocial phenomenon have been incorporated into 
policy, healthcare and science settings. International organisations, like the World Health 
Organisation (WHO) and the World Organisation for Animal Health (OIE), and national 
governments develop antibiotic prescription protocols and standards for infection 
management, introduce quarantine practices for patients with suspected AMR infections and 
allocate funding for the development of new medicines and scientific research (O’Neill, 2016; 
WHO, 2015). These actions have been criticized by researchers in both the biomedical and 
social sciences for being too technical and for not addressing the multi-sectorial nature of AMR 
(Chandler, 2019; Hinchliffe et al., 2018; Larsson, 2014). The microbiologist Larsson (2014) 
stresses that it is important to look beyond the prescription of antibiotics and to address the 
economic and political conditions that allow pharmaceutical companies to establish their 
factories in countries like India and pollute the local environments with antibiotic waste. The 
anthropologist Chandler (2019) argues that campaigns targeting the individual behaviour of 
patients or prescribers do not acknowledge the significance of social, political and economic 





turn, influence behavioural practices. Therefore, the world of AMR presents ambiguities, 
contrasts and controversies when it comes to defining and dealing with this phenomenon. 
Against the background of these discussions about AMR and how to tackle it, in this thesis 
I aim to gain more insight into how AMR is incorporated and practised in different settings of 
policy, healthcare and science and what kind of reality is constructed through these practices.  
Before starting the journey into this AMR Wonderland, I will give an overview of relevant 
background information, which will help in navigating through different settings and practices. 
I will first sketch how starting from the development of the first antibiotics, bacteriologists and 
medical professionals aimed to construct AMR as a major public health issue. I will then 
present how current international health policies deal with this issue. Following this, I will 
introduce how social scientists have proposed to study AMR. After having explained my 
methodological approach, I will elaborate on the structure of this thesis.  
The historical construction of AMR: from a laboratory to policy agenda 
To understand how AMR has become a concern for public health globally, I will give a 
sketch of the historical constructions of this phenomenon that is related to the invention and 
use of antibiotics. In his Nobel Prize lecture in 1945, Fleming shared his experience of 
observing a penicillin production factory in the US: 
I had the opportunity this summer of seeing in America some of the large penicillin 
factories which have been erected at enormous cost and in which the mould was growing 
in large tanks aerated and violently agitated. To me it was of especial interest to see how 
a simple observation made in a hospital bacteriological laboratory in London had 
eventually developed into a large industry and how what everyone at one time thought was 
merely one of my toys had by purification become the nearest approach to the ideal 
substance for curing many of our common infections. 
This observation captures the infrastructural transformations and increasing expansion of 
antibiotics from one laboratory in the UK to industrial factories all over the world. Such 
expansion was possible due to the integration of antibiotics, starting from penicillin, into all 
spheres of life, including healthcare, hygiene, policy-making, scientific research, agriculture 
and animal husbandry. In the 1960s and 1970s, AMR was not considered a major public health 
problem, to the point that in 1978 Petersdorf, one of the world’s leading infectious disease 
specialists of that time, argued that infectious disease was a speciality that might no longer be 





loyalty to infectious disease, I cannot conceive of the need for 309 more [graduating trainees 
in] infectious disease . . . unless they spend their time culturing each other’ (Spellberg, 2008). 
Thirty-three years later the WHO announced that AMR is ‘a threat to all branches of medical 
and public health practice’, which requires an increase in infectious disease expertise (Leung 
et al., 2011). 
Several historical studies have provided insights into the dynamics of how AMR has 
steadily become a public health concern of global importance. In his work Penicillin: Triumph 
and Tragedy, Bud (2007) investigates the history of the discovery and global popularisation of 
penicillin in the second half of the 20th century, which took place in the broader socio-political 
context of the post-war era. Bud describes that prevention of infectious diseases before the 
introduction of penicillin in the UK and the US was characterized by moralistic framings of 
hygiene. Hygiene and health were associated with the moral character of people. He elaborates: 
Whether qualified as ‘personal’ or ‘social’ hygiene, this involved not just a variety of 
exacting precautions [i.e. ‘efficient sewage disposal and clean water supplies’], but also 
the more general taking of a personal responsibility for one’s own welfare. Approved 
medical practices were linked therefore with moral responsibility for staying healthy and 
with the implication of moral failure in the case of illness. (p. 5)  
The moralistic undertones of infectious disease prevention, as Bud argues, changed with the 
introduction of penicillin. Infection prevention and treatment became conceptualised as a 
‘pharmaceutical cure’.  
By analysing the creation and global dissemination of the pharmaceutical model for 
infection treatment in the post-war era, Bud (2007) shows that mass-production of penicillin 
was introduced in a very specific context immediately after the Second World War, when 
people were craving positive changes. 
Penicillin became available to patients at a time when publics across the world yearned for 
good news. It was not just the war itself that was wearying. In many countries, rationing 
lasted till well after the Second World War. Even in Canada it outlasted the war by two 
years, and other less well-endowed countries suffered longer. The very word ‘austerity’ 
long evoked the legacy of the post-war years. Against the shortage of many luxuries, 
penicillin was a symbol of the wider range of effective medicines then becoming available. 





His study shows that after the war, penicillin, and later other antibiotics, gained tremendous 
public attention. Pharmaceutical companies advertised the healing capacities of the wonder 
drugs; scientists published articles describing the newly discovered effects of antibiotics; 
newspapers published interviews and stories with researchers, doctors and recovered patients. 
Therefore, patients, medical doctors, industry and science together established a new doctrine 
which proclaimed that infections were not a moral responsibility but rather ‘a technical 
problem susceptible to a pharmaceutical solution’ (Bud, 2007). 
Bud (2007) shows that the rise of penicillin popularity in the post-war years was 
accompanied by warnings from several bacteriologists who pointed out the potential 
development of resistance in bacteria. However, despite these warnings, in the 1950s and 1960s 
pharmaceutical companies started a race for new antibiotic types to meet the rising global 
demand. Bud (2007) states that the first restriction on over-the-counter sales of antibiotics was 
introduced in the US in 1951, but it was justified by the ‘danger of allergic reaction threatening 
unsuspecting users’, rather than by AMR. Although cases of antibiotic-resistant Streptococcus 
have been rising in different parts of the world since the 1950s, with the first recorded lethal 
case of methicillin-resistant Staphylococcus aureus in the US in 1962, the development of new 
antibiotics remained to be the main instrument for tackling infections.  
It was not until the 1980s, according to Bud (2007), that AMR started to gain political 
attention. He argues that AMR was established as an issue of public concern before entering a 
policy agenda. He shows that starting in the 1960s several bacteriologists and medical 
specialists were addressing AMR as an increasing risk to healthcare practices. They argued 
that due to the increased popularity of antibiotics, the hygienic measures in hospitals had started 
to deteriorate, and surgeons were performing risky operations without following strict hygienic 
rules, relying solely on antibiotics. In addition, some medical doctors were criticising patients’ 
demands for antibiotics, which they explained by the influence of antibiotic advertisement 
campaigns. Bud (2007) concludes that in the 1980s rising concerns about AMR in the 
biomedical community, as well as the rise of Staphylococcus-resistant infections in different 
parts of the world, including lethal cases, contributed to making AMR an issue of political 
concern globally; it was then included into the agenda of the WHO.  
Similar to Bud (2007), Podolsky (2015) argues in his book The Antibiotic Era: Reform, 
Resistance, and the Pursuit of a Rational Therapeutics that AMR became an issue of global 
political concern around the 1980s. But while Bud (2007) focuses on the development and use 
of antibiotics, Podolsky analyses the history of antibiotic regulations from the 1940s onwards, 





from the regulations of the ‘inappropriate pharmaceutical marketing of inappropriate drugs’, 
and moves on to the analysis of the regulations of the ‘inappropriate prescribing of appropriate 
drugs’ (Podolsky, 2015, emphasis original). He gives the following description of the 1940s–
1950s social context that sparked the development of antibiotic policies:   
Yet the placidity of the era – when the most frightening situation a clinician would 
apparently find himself in was as a ‘fielder trying to catch a dozen fly balls [pharmaceutical 
options] at once’ – would be shaken by the mid-1950s by several phenomena: the 
seemingly unfettered proliferation and marketing of the wonder drugs, the increasingly 
recognised costs and adverse effects (allergic and otherwise) of antibiotics, novel 
syndromes of ‘superinfection’ resulting from alterations in patients’ microbial florae, 
apparently correlated diagnostic sloppiness, and finally, increasingly documented 
antibiotic resistance, particularly among the feared staphylococci. (p. 38) 
Podolsky (2015) describes that in the early 1950s policy attention was focused on the 
efficacy of antibiotics and the development of rational therapeutics practices. He elaborates 
that clinical trials of medicines were the central concern for early reformers. In addition to the 
efficacy of medications, medical regimens were a priority question for governing antibiotics. 
Podolsky (2015) shows that at the beginning of antibiotic reforms there were several actors 
involved in the construction of rational antibiotic practices – pharmaceutical companies, 
scientists and policymakers. 
Similar to Bud (2007), Podolsky (2015) shows that the rise of political attention to AMR 
started around the 1980s when biomedical scientists began to actively voice their concerns 
about this issue.  He describes how in 1981 during the Molecular Biology, Pathogenicity, and 
Ecology of Bacterial Plasmids conference in Santo Domingo, 147 scientists from different 
parts of the world signed the ‘Statement Regarding Worldwide Antibiotic Misuse’ where they 
argued that AMR should be understood and addressed as a ‘neglected health problem’ 
(Statement regarding worldwide antibiotic misuse, 1981). According to Podolsky (2015), the 
rising concerns of the scientific community about AMR attracted the attention of reformers of 
practices regarding antibiotic use and prescription. 
Podolsky (2015) shows that the interest of medical doctors and patients became part of 
AMR regulations preceding the significant rise of public and policy attention to this issue in 
the 1990s. He describes how at that time newspapers like the Times and Newsweek started to 





Such attention, Podolsky (2015) argues, resulted in an increase in funding for infectious 
diseases and AMR research and treatment. For instance, he shows how the US Centre for 
Disease Control increased its funding for emerging infections from ‘$1 million in 1994 to $7.7 
million in 1995 to $59.1 million in 1998’. Apart from the US, since the end of the 1980s and 
the beginning of the 1990s AMR has gained international attention, and the WHO in 1985 
established the Collaborating Centre for Surveillance of Antimicrobial Resistance 
(WHONET), in 2001 introduced the WHO Global Strategy for Containment of Antimicrobial 
Resistance, and in 2015 the Global Action Plan on Antimicrobial Resistance.  
With the rise of political attention to AMR in the 1990s, the antibiotic behaviours of 
medical doctors and patients have often been problematised as a cause of this problem (Bud, 
2007; Podolsky, 2015). However, several decades before that, AMR in humans had already 
been explained by the extensive use of antibiotics in animals and agriculture. In his book, Bud 
(2007) shows that after the Second World War antibiotics not only became important for the 
treatment of infections in humans but were also a crucial ingredient of a farming industry that 
was rapidly growing. He argues that since the 1950s, ‘antibiotics had become a high technology 
solution to the problems of newly intensive farming’. Antibiotics were increasingly used for 
treatment and prevention of infections in animals, growth promotion, and food conservation. 
Although there were some attempts to control and limit the use of antibiotics in farming and 
agriculture, Bud (2007) shows that such attempts were not very successful. He mentions two 
reasons for this: first, resistance by the farming community and involvement of strong 
economic interests and second, disagreements between scientists and policymakers about the 
potential AMR risks of antibiotic use in farming on human health. 
In line with the analysis of Bud (2007), the German historian Kirchhelle (2018b), in his 
article ‘Swann Song: Antibiotic Regulation in British Livestock Production (1953–2006)’, 
specifically focusses on the scientific and political controversy around the potential risks of 
AMR that antibiotic use in farming can cause in humans. He analyses the history of this 
controversy in the UK starting from 1953 and shows attempts to pacify it through the  
establishment of the Joint Committee on the Use of Antibiotics in Animal Husbandry and 
Veterinary Medicine in 1968. This committee was coordinated by the molecular biologist 
Michael Swann, and it was installed to analyse and bring a solution to the sharp increase of 
antibiotic consumption in farming, which by 1963 had reached the point where 44% of 
antibiotics in the UK were fed to animals.  
After a year of work, in 1969 the committee produced the Swann Report. Kirchhelle 





that were therapeutically relevant for human health and antibiotics that were therapeutically 
irrelevant for human health, and for stating that only the latter were allowed to be applied in 
animal treatment and growth promotion. He argues that this report was a compromise between 
economic demands of the food production sector and public health concerns, and it gained 
widespread popularity in and beyond the UK and determined the trajectory of European 
antibiotic regulations for the next several decades. However, he concludes that the report did 
not make a significant difference in antibiotic practices in farming.  
Aiming to satisfy all parties within the corporatist decision-making framework, the 
report’s recommendations made little difference on farmers and even less difference for 
bacteria. (p. 349) 
Broadening the focus from the UK to other parts of the world, in his other article ‘Pharming 
animals: A global history of antibiotics in food production (1937-2017)’ Kirchhelle (2018a) 
analyses how antibiotics were used and regulated in different countries, not only in farming 
but also in agriculture. Similar to his analysis of the UK context, focusing on different food 
production settings around the world, Kirchhelle (2018a) concludes that increased economic 
demand for farming products in combination with easy access to antibiotics and poor policy 
regulations in this area made the use of antibiotics a mundane practice. His work highlights 
how political economy and demands for food production became intertwined with the 
antibiotic production industry, which simultaneously provoked the debates about the potential 
risks of AMR for human health.  
The two intertwined histories of antibiotic use in humans and animals described by Bud 
(2007), Podolsky (2015) and Kirchhelle (2018b, 2018a) provide important insights into how 
AMR has been constructed in public health and policy arenas. Although several bacteriologists 
have argued about the importance of AMR for human health since the introduction of 
penicillin, but the economic demands and healing capacities of this drug superseded these 
warnings. Interestingly, while human practices of antibiotic use became seen as a cause of 
AMR only at the end of the 1990s, antibiotic use in animals and agriculture has been considered 
to be a risk factor for human health since the 1960s. The controversy surrounding antibiotic 
use practices in non-human sectors and their impact on humans has still not been resolved in 
microbiology, with new studies arguing that the connection between the two sectors may not 
be that strong (Wu et al., 2013). Despite this uncertainty, there have been numerous attempts 





sectors by allowing them to use different antibiotics, but as we could see from the research of 
Kirchhelle (2018b) this approach did not make much difference to AMR. In contrast to the 
Swann Report, since the introduction of the Global Action Plan on AMR in 2015, the policy 
approach of One Health has been introduced to regulate the uncertain connection between 
human and animal use of antibiotics by addressing it as a shared concern. The influence of this 
approach to AMR is still unclear, and this is one of the questions that I aim to reflect upon in 
this thesis. 
Construction of the One Health policy approach to addressing AMR 
The history of antibiotic development and the increased concern for AMR have shown that 
this phenomenon has been defined and re-defined by various stakeholders debating its 
importance and relevance for public health. We can see that different policy control instruments 
have been implemented to tackle AMR: the prohibition of antibiotic advertisement and self-
treatment, attempts to control antibiotic use in farming and control of medical prescriptions. 
The regulations on antibiotic use in both human and animal health sectors has been one of the 
major controversies in the history of AMR, which continues to the present day. The Swann 
Report tried to separate the human and animal sectors by allowing the use of different 
antibiotics, but not much progress has been made in decreasing AMR. Currently, a new policy 
paradigm is taking the lead in the arena of AMR – the One Health approach – which, contrary 
to the Swann Report, aims to coordinate human and animal health sectors by connecting rather 
than separating them from each other.  
The One Health approach to health highlights the connectivity and interdependency 
between the human, animal and environmental health. This approach is not new. It can even 
be traced back to ancient Greek medicine: the Greek physician Hippocrates stressed the 
dependency of human health on seasonal and environmental factors in 400 BCE (Miller, 1962). 
The 19th-century German physician Virchow coined the term zoonosis to highlight the 
interdependency between human and animal health, and he introduced the notion of One 
Medicine to underline the importance of collaboration between human and animal medicine. 
The concept of One Medicine was not widely accepted during his life (Schultz, 2008), but it 
was picked up again by the parasitologist Shwabe (1984), who argued that human and animal 
health are interconnected and therefore should be studied in cooperation. Although the concept 
of One Medicine was not widely accepted in the public health arena, the concept of zoonosis 
and the idea of dependency between human and animal health did attract the attention of health 





parts of the world, debating different approaches to zoonotic diseases, participated in the 
international symposium Building Interdisciplinary Bridges to Health in a Globalized World, 
hosted by Rockefeller University in the US. This symposium resulted in 12 principles of One 
Health known as the ‘Manhattan Principles’, which major aim was to emphasize a ‘link 
between human, domestic animal, and wildlife health’ (Centers for Disease Control and 
Prevention, 2004).  
Following the conference, the One Health approach became widely adapted to address 
different zoonoses, and it became a central concept to bridge the work of international 
organisations such as the WHO, the OIE and the Food and Agriculture Organisation of the 
United Nations (FAO). Following these developments, the concept of One Health has become 
gradually incorporated into AMR policy agendas. The 2015 Global Action Plan elaborated that 
AMR is an interest of everyone’s concern that requires collaboration between and within 
professions from human and animal sectors. The One Health approach in this document is 
defined through ‘coordination among numerous international sectors and actors, including 
human and veterinary medicine, agriculture, finance, environment, and well-informed 
consumers’(WHO, 2015). In the 2017 European Action Plan against AMR, the concept of One 
Health also occupies a central position, it even became a part of its title – A European One 
Health Action Plan against Antimicrobial Resistance. The European Action Plan defines One 
Health as follows:  
One Health is a term used to describe a principle which recognizes that human and animal 
health are interconnected, that diseases are transmitted from humans to animals and vice 
versa and must therefore be tackled in both. The One Health approach also encompasses 
the environment, another link between humans and animals and likewise a potential source 
of new resistant microorganisms (p. 4). 
While in the 20th century microbiologists problematised both the use of antibiotics in humans 
and animals, which resulted in fierce debates about the connection between human and animal 
health, the policy regulations of the 21st century made this argument central to addressing 
AMR and concluded that these health sectors must be coordinated together. 
The focus on the One Health approach to AMR has made human-animal relations central 
to addressing this phenomenon, and it has been analysed and reflected upon by different 
scholars. In her book One Health and the Politics of Antimicrobial Resistance, the physician 





AMR regulations. She conducted a historical analysis of the controversy related to the 
regulations of antibiotics in human and animal sectors in different countries. This controversy, 
as was mentioned in the previous section, centred on the potential of antibiotic use in animals 
to cause harm in humans. Applying the One Health approach as an analytical framework, she 
shows that this framework should be dominant in developing policy regulations for AMR. 
Therefore, she emphasizes that ‘ultimately, the goal for both public health and agriculture 
should be to optimize human, animal, and environmental health: in essence, One Health’ 
(Kahn, 2016). 
Other scholars have been more critical about One Health and the connection between the 
health of humans and animals that it highlights. Studying the history of policy responses to 
livestock-associated zoonoses in the Netherlands in the 20th century, Haalboom (2017) argues 
that the agricultural and farming sectors have always held dominance over the public health 
domain in terms of defining shared health problems. She explains that deep financial interests 
involved in the farming sector granted them ‘primary ownership’ over zoonotic diseases, which 
have been defined as economic rather than public health problems.  
At the same time, a different perspective on the concept of One Health in its application 
to zoonoses was introduced by Craddock and Hinchliffe (2015), who argue that the current 
formulation of One Health in policy regulations seems to propose a top-down approach 
between human and animal sectors, where the human sector leads. They point out that instead 
of building bridges between different sectors, One Health makes the human health sector the 
authority in the field that can dictate regulations for animal and environmental sectors. Similar 
arguments have been made by the proponents of the EcoHealth approach who have  highlighted 
that health should be understood and addressed in the context of ecosystems and not only 
human-animal relations (Mi et al., 2016; Zinsstag, 2012). In contrast to One Health, the 
EcoHealth approach shifts its focus from disease threats to wider environmental understanding 
of health and illness (Roger et al., 2016).  In addition, Craddock and Hinchliffe (2015) elaborate 
that the One Health approach to policy regulations tends to prioritise knowledge produced by 
biomedical professionals in the human health field, while often not taking into account other 
forms of knowledge produced in animal and environmental sectors and by social sciences.  
While the concept of One Health and the different modes of relations that it builds between 
the human and animal sectors have been reflected in the context of zoonotic diseases, similar 
reflections in relation to AMR are currently lacking. Applying the One Health approach to 





regulations. Therefore, it is still unclear how it may influence the ongoing controversy 
surrounding the connection between the health of humans and animals. 
Social science approaches to the construction of AMR 
In biomedical sciences, AMR has been researched and debated since the introduction of 
penicillin. Bacteriologists have been lobbying for the recognition of AMR as a major public 
health concern and have been arguing about the biological connections between AMR in 
humans and animals. Parallel to these constructions of AMR as a biomedical phenomenon, 
social science scholars have analysed and developed various understandings of the social 
nature of AMR. Social scientists have been developing knowledge about different practices of 
antibiotic use by healthcare professionals, patients and farmers (Barden et al., 1998; Boyd, 
2001; Mangione-Smith et al., 1999). These studies have articulated that antibiotic practices are 
shaped by different social processes, including economic access to healthcare and the ability 
to take sick leave, and by market demands for larger quantities of food.  
The same year as the publication of the Global Action Plan, the British professor of health 
system economics Richard Smith published a commentary in the British Medical Journal 
highlighting the importance of social science research to addressing AMR. He argues that to 
understand the mechanisms of AMR, it is crucial to analyse how antibiotics are embedded into 
the daily reality of professionals and laypeople. Along with this call for deeper engagement 
with social sciences, in 2016 a group of anthropologists from the London School of Hygiene 
and Tropical Medicine released a report arguing that AMR should be understood as a 
phenomenon that is made and remade in different settings and practices, rather than as a static 
biomedical fact (Chandler et al., 2016). Hence, they propose three potential settings where this 
phenomenon can be analysed: practices of healthcare professionals and laypeople, policy 
regulations and scientific practices of knowledge production (Chandler et al., 2016). The 
authors suggest these broad settings as a starting point for understanding how AMR is shaped 
and, at the same time, how it can influence the settings where it is shaped. This understanding, 
they argue, is important for addressing AMR as a biosocial phenomenon that is made by 
different practices depending on the social world where it is situated.  
In line with the suggestions in the report, several studies have analysed how patients and 
prescribers in different settings give meaning to antibiotics in everyday life, and they have 
shown the range of conceptualisations of this medicine. In an anthropological study, Lambert 
et al. (2019) show how practices of antibiotic prescription in a rural province of China present 





Chinese ideas about how inflammations can be treated with traditional medicines. The authors 
argue that local practices of antibiotic prescription should be understood as a result of 
conceptual and linguistic overlaps between the concept of infection and the concept of 
inflammation. These overlaps mean that medical doctors have to bridge the two different 
concepts in their antibiotic practices. Such analysis goes beyond the understanding of antibiotic 
prescription as something based on biomedical knowledge, but it shows how antibiotic 
practices are embedded in a particular setting.  
Similarly, Broom et al. (2014) show how antibiotic prescription practices in an Australian 
urban hospital are determined by local rules of professional communication. These authors 
show that the need to prevent AMR has a limited significance in the decision of medical doctors 
to prescribe antibiotics; rather, antibiotic prescription can be motivated by factors like the fear 
of undertreating patients or by forms of professional etiquette which imply that decisions of 
colleague clinicians to prescribe antibiotics should not be questioned. In both cases, in 
healthcare settings in China and Australia, antibiotic prescription practices were determined by 
the social worlds in which these practices took place. Therefore, distinctive approaches would 
be required to address AMR as a phenomenon that is unique depending on the setting. Without 
the engagement of qualitative social sciences, these crucial nuances could be overlooked in 
policymaking. 
Another setting that Chandler et al. (2016) emphasise as important for social studies of 
AMR is policy regulations. They argue that analysis of national and international policy 
discourses gives an important understanding of how AMR is imagined and how responsibilities 
for control over antibiotic use are distributed. For instance, Brown and Nettleton (2016) show 
how in UK policies on AMR economic considerations play a major role. AMR is presented as 
an issue of primarily economic concern that increases the cost of healthcare and that can be 
addressed through investments in the development of new medications. The same authors 
demonstrate that, partly in line with economic considerations, AMR is constructed in policy 
discourses as a foreign threat, which means that incoming migrants are presented as carriers of 
AMR who can disseminate it among the UK public. Brown and Nettleton (2016) argue that 
this framing of AMR can be used by policymakers to justify strict migration policies.  
Social scientists like Chandler (2019) and Will (2018) have critically analysed the 
individualist tone of many policies for AMR prevention: these policies focus on changing the 
individual behaviour of prescribers and users of antibiotics. Both authors highlight that policies 
that focus on behavioural changes fail to address the structural processes that influence 





addition, these authors argue that focus on behaviour runs the risk of allocating responsibility 
for AMR development on individuals whose practices can be determined not simply by their 
lack of knowledge but by their inability to get access to healthcare and non-antibiotic treatment. 
The third setting where, according to Chandler et al. (2016), social science research can 
play an important role is in practices of science and production of scientific knowledge. They 
argue that the conceptual frameworks developed in science and technology studies (STS) can 
help analyse the processes of scientific fact production about AMR. STS can be broadly 
described as an area of study that analyses scientific facts and the production of those facts as 
intrinsically social and political (Edge, 1995). Chandler et al. (2016) refer to the famous study 
Laboratory life: The construction of scientific facts by Latour and Woolgar (1986). In this 
study, Latour and Woolgar (1986) argue that scientific facts are constructed through the 
processes of communication, negotiation and re-negotiation of these facts between scientists, 
funders and policymakers. The authors conducted a two-year ethnography at the Roger 
Guillemin laboratory at the Salk Institute for Biological Studies and showed how the 
knowledge produced in the laboratory was discussed and contested in scientific literature, 
scientific conferences and meetings before it became stabilised as a fact. Analysing the process 
of AMR scientific fact production, Nerlich and James (2009) focus on how this phenomenon 
was imagined by microbiologists at the end of the 1990s and beginning of the 2000s. They 
show that microbiologists were using the metaphors of catastrophe and apocalypse to 
communicate scientific facts about AMR to health professionals, policymakers and laypeople. 
They argued that these specific metaphors were used to construct AMR as an urgent public 
health phenomenon and to attract policy attention and funding to AMR research (Nerlich & 
James, 2009).  
The analysis of antibiotic practices in the three different settings proposed by Chandler et 
al. (2016) facilitates understanding into how antibiotics are embedded into policy discourses, 
scientific knowledge production, and the modern infrastructures of healthcare and farming. In 
her research on the history of biological developments of antibiotics, Landecker (2015) 
suggests that antibiotics themselves become infrastructural. She explains that antibiotics have 
become an inevitable part of the idea of health, hygiene and farming. Medical doctors and 
patients build their relationships around the prescription of medications where antibiotics 
themselves become a form of care and an artefact that represents scientific knowledge 
(Chandler et al., 2017; van der Geest & Whyte, 1989). Similar to the suggestion of Landecker 
(2015) and following the work of Bowker and Star (2000) on classifications as information 





concept of infrastructure. She applies a broad definition of infrastructure as something that 
arranges and organises the work of its heterogeneous users. These infrastructures can be 
physical tools like surgical instruments, the organisation of a hospital on different wards, or an 
idea or a concept, like etiquette rules for communication with others. These infrastructures are 
usually invisible to their users unless there is an inversion – a breakage of the infrastructure; 
for instance, if there are more patients with infectious diseases than there are beds in a hospital, 
we recognise the limits and gaps of the existing hospital infrastructures. 
Chandler (2019) shows that antibiotics can be understood as infrastructure because they 
construct the modern concepts and practices of health, productivity and sufficient 
convalescence. In this context, AMR can be seen as an inversion of these infrastructures – 
something that breaks them down and makes them visible. She concludes that the rise of AMR 
concerns has led to the deconstruction of antibiotic infrastructures – it shows the dependency 
of modern economic, social and political processes on these medicines.  
The present moment of antimicrobial resistance as a major topic of global concern can be 
understood to represent a moment of inversion—when antimicrobials have been rendered 
visible where previously they have been a part of the woodwork (p. 9). 
Working with the concept of infrastructure, Chandler (2019) suggests that AMR makes 
the work of antibiotics visible – it shows how different antibiotic practices have been 
established and function in various settings. AMR, Chandler (2019) argues, disturbs the 
established practices and infrastructures in which antibiotics are embedded. Social science 
scholars have developed extensive expertise on the study of antibiotic practices in different 
settings and by various stakeholders (Broom et al., 2015; Hinchliffe et al., 2018; Lambert et 
al., 2019). However, the number of studies focused on the inversions of antibiotic 
infrastructures and adaptive practices shaped by AMR have been limited. Therefore, this thesis 
shifts the focus from antibiotic practices to infrastructural disturbances introduced by AMR 
and the biosocial world that these disturbances shape.  
Methodological approach 
The literature on AMR shows that this phenomenon can take various shapes and produce 
different practices depending on the social world where it takes place. Informed by these 
studies, I visited practices shaped in policies, healthcare and science to study how AMR is 





from the social sciences and humanities. I applied different qualitative methods, including 
observations, interviews, focus groups, discourse analysis and conceptual analysis. 
To study policy practices, I used discourse analysis. I focused the analysis on the emerging 
concept of One Health and analysed the meanings of this concept for international policy 
regulations on AMR.  
During my journey through practices of healthcare, I combined different methods. This 
journey brought me to a refugee centre in the Netherlands and the hospitals and pharmacies in 
Russia. In both settings, I conducted in-depth interviews with local residents – refugees, 
microbiologists, nurses, clinicians, patients and pharmacists. In the Dutch study, I also 
conducted two focus groups with public health professionals and I performed observations in 
two refugee centres to understand the daily routines of their residents.  
To study scientific practices about AMR, I also combined several methods. I conducted a 
discourse analysis of microbiological research articles to gain a deeper understanding of how 
microbiologists imagine AMR and travelling. I analysed semi-structured interviews with 
students who travelled from different parts of the world to India, in which they discussed how 
they understood AMR and travelling. I also conceptualized how microbiological data based on 
the analysis of stool samples from these travelling students could come into a dialogue with 
the analysis of the interviews and what such dialogue would mean for AMR.  
In each of the chapters, I will present more details about the methods that I applied in that 
specific study. 
Outline of the thesis 
This thesis focuses on how AMR is practised in different settings – in policies, healthcare 
and science. In Chapter 1 I study how the idea of One Health and specifically the relations 
between the health of humans, animals and environments are constructed to address AMR in 
the international policy arena. To that purpose, I analyse influential international AMR policy 
regulations and study how the One Health approach is conceptualized in these documents. The 
analysis is conducted in two steps: first, I analyse general international health policy regulations 
that form the basis for AMR One Health policies and second, I analyse international policies 
that consider One Health the main approach for addressing AMR.  
The next two chapters are dedicated to different antibiotic practices exercised by health 
professionals and laypeople. In Chapter 2 I analyse practices of AMR control in public health. 
Against background discussions about AMR screening of refugees, this chapter explores 





public health doctors, public health nurses and microbiologists, I analyse the perspectives of 
these stakeholders on AMR screening. Chapter 3 moves from public health to clinical settings, 
namely primary care clinics in Russia. I analyse how medical doctors, pharmacists and patients 
shape communication and everyday antibiotic practices in a context of increasing control of 
over-the-counter antibiotic sale and the introduction of obligatory medical prescriptions. 
The next two chapters deal with the scientific arena of AMR. In Chapter 4, I analyse how 
microbiological research imagines AMR and its dissemination through human travelling. 
Focusing on the analysis of metaphors in microbiological discourses of AMR in travellers, this 
chapter elaborates how different elements – travellers, bacteria, countries of origin and 
countries of destination – shape the notions of health and health risks concerning AMR. In the 
context of the increasing calls for transdisciplinary research in AMR, Chapter 5 explores the 
possibility to combine microbiological and social science methods and insights to address 
AMR. This combined methodology allows the investigation of the potential of 
transdisciplinary approaches for addressing AMR as a biosocial phenomenon. Chapter 6 is a 
short commentary-reflection on my own journey through the worlds of AMR as a member of 
a transdisciplinary research team.  
In the conclusion, I summarise the results of my travels through different AMR practices 
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One Health (OH) is an increasingly popular approach for addressing antimicrobial 
resistance (AMR) which is often presented as a shared health concern at the interface of human-
animal-environment relations. OH is widely adopted as a framework for collaboration between 
organisations like the World Health Organisation and the World Organisation for Animal 
Health; furthermore, it occupies a central position in international AMR policy documents. 
Scholars like Craddock and Hinchliffe have raised questions about whether a unified OH 
understanding of health allows us to comprehend the diversity of practices and knowledge 
involved in transdisciplinary and inter-organisational collaborations. In this article, we aim to 
explore how the OH idea as a shared health concern is conceptualised in international responses 
to AMR. Therefore, we conducted a constructivist policy analysis of two types of international 
policy documents – 11 documents dedicated to AMR and a OH approach to it, and 12 
documents with a focus on more general health issues that AMR regulations are built upon. 
The analysis of this policy arena makes clear that both sets of documents put human health at 
the centre, while the animal and environmental sectors are primarily framed as a risk for human 
health. Although human health is, more or less explicitly, considered to be the main problem, 
the animal and environmental health sectors are assigned responsibility for addressing this 
problem.  
  






Within three decades after the introduction of penicillin, antibiotics have occupied an 
essential role not only in human medicine but also in the veterinary and agricultural sectors. 
The history of the interrelations and conflicts between the human and non-human health sectors 
in Europe, as it was described by Kirchhelle (2018b, 2018a), shows how antibiotics became 
intertwined with health, sanitation, and food infrastructures, thus also shaping ‘antibiotic 
infrastructures’. Antibiotics as infrastructure – ‘usable systems that are unnoticeable unless 
disrupted (Bowker & Star, 2000) – have been elaborated upon by Chandler (2019) and 
Chandler et al. (2016) to highlight how antibiotics are embedded into health and economic 
infrastructures through the ideas of sanitation, food production, healthy body, and human 
productivity. Such infrastructures can be seen as platforms that bring together the human, 
animal and environmental sectors. For instance, the spread of zoonotic diseases has led to close 
collaboration as well as shared health and sanitation practices between stakeholders dealing 
with human health, farming, and wildlife (Chien, 2013). At the same time, the rise of concerns 
over antimicrobial resistance (AMR) can intensify the competition between these sectors over 
the scarce resources of antibiotics (Chandler, 2019). Although both the human and animal 
sectors share a common aim to address zoonotic diseases, the means to achieve this aim may 
vary. While the human sector may focus on the optimisation of antibiotic prescription to 
maximise healthy living, the animal sector can be more economically driven and focuses on 
the maximisation of meat production (Degeling et al., 2017).  
In an attempt to develop a comprehensive regulatory mechanism of inter-sectoral 
cooperation, a One Health (OH) policy framework has been adopted by international 
organisations such as the World Health Organisation (WHO), the World Organisation for 
Animal Health (OIE), and the Food and Agriculture Organisation of the United Nations (FAO). 
Starting from 2008 this framework has been explicitly utilised to address avian influenza 
(Chien, 2013). Since then, OH has become increasingly popular in the scientific and political 
arena for addressing such health issues as food safety, zoonoses, and AMR (Bidaisee & 
Macpherson, 2014; Coker et al., 2011; Kakkar & Abbas, 2011; Lee & Brumme, 2013).  
While the OH framework for collaboration has occupied a central position in international 
health policy, health professionals have demonstrated different interpretations to this approach. 
A Delphi survey among human and animal health practitioners conducted in Australia by 
Degeling et al. (2017) revealed a variety of disagreements when prioritising between human 
health, animal health, and economic considerations. For instance, the survey showed that when 





higher ranking to the emotional wellbeing of people, while those from the animal health sector 
gave greater consideration to animal health and economic concerns. In addition, in public 
health literature OH is described in different ways: as ‘a seamless interaction between 
veterinary and human medicine’ (Calistri et al., 2013), or as a ‘perspective, covering animals 
and humans [...] as well as the environment’ (O’Neill, 2016). Therefore, a tension arises in the 
AMR field between the search for a unified OH approach to address shared health concerns 
and the diverse priorities within this approach.  
The OH search for consensus in explaining and addressing shared health concerns has 
been scrutinised by Hinchliffe (2015). He argues that a unified ‘One World One Health 
approach runs the risk of reducing the diversity of knowledge, practices, and values, i.e. the 
diversity of worlds, that are involved in the process of health making. Hinchliffe (2015) 
elaborates that through the attempt to give a unified explanation and propose a single solution 
for a shared health issue, OH has a tendency of reducing the complexity of interrelations 
between practices that take place in farms, clinics, or laboratories. Another social science 
researcher, Craddock (2015), argues that inter-organisational collaborations may reflect 
conflicting values and interests of the involved organisations. She gives an example of product 
development partnerships for a tuberculosis vaccine and explains that pharmaceutical 
companies involved in such partnerships often focus on ‘markets rather than diseases burdens. 
An example can be found in the 2010 response to Q-fever in the Netherlands that caused 
substantial damage to Dutch farmers. Because Q-fever is not severe in animals, no mandatory 
vaccination was required, however, after the 2009 Q-fever outbreak in humans, it was decided 
to cull 40,000 pregnant goats in the hope that it would prevent further human outbreaks 
(Enserink, 2010). Craddock (2015) argues that the OH framework for collaboration can 
underline the power-dynamics between involved actors, such as pharmaceutical companies and 
small research centres, or, as illustrated in the second example, farmers and medical 
professionals.  
Despite the ambiguous nature of OH discussed by Hinchliffe (2015) and Craddock (2015), 
Chien (2013) explains that it can be a suitable collaboration framework for international health 
agencies, such as the WHO, the FAO, and the OIE. This framework, she argues, can help to 
reduce conflicting interests and to improve communication between these organisations. 
Drawing on interviews with officials from international health organisations, Chien (2013) 
shows that OH has been perceived as a fruitful strategy for collaboration that allows the 
expertise of different organisations to complement each other without prioritising one over 
another.  





Inquiries into the way OH aims to shape a unified understanding of health, and the 
ambiguities involved in such unified concepts raise the question of how the notion of OH is 
conceptualised in international health policy. To explore this question, we will focus on a 
product of OH collaborations, that is, international health policy documents. We will narrow 
our analysis to AMR policy documents, which is one of the areas where OH has become 
increasingly popular. Inspired by social science literature regarding the ambiguity of OH, here 
we aim to understand whether OH policy documents shape a unified AMR world, how it links 
and incorporates the diversity of human-animal-environmental knowledge on AMR, and what 
kind of collaborations and solutions to address AMR it suggests.  
Theoretical approach  
To analyse policy documents, we draw from constructivist policy analysis, and especially 
the work of Gusfield (1984) and Stone (2012). Both scholars have demonstrated how policy 
discourses are not neutral technical representations of problems and solutions, but specific 
normative constructions of reality. In his analysis of traffic regulation policies in the US, the 
sociologist Gusfield (1984) demonstrated, for instance, how dominant policy discourses 
implicitly constructed traffic accidents as being caused by the drivers, and not by, for instance, 
technological characteristics of the cars or motorway infrastructures. These policies presented 
‘drunk driving as the cause of accidents. At the same time, a city infrastructure, which implied 
that all pubs could only be reached through the highway, was not at the focus of attention. It is 
not to say that drivers who consume alcohol were not contributing to traffic accidents, or that 
car characteristics did not cause these problems, rather, in his analysis Gusfield (1984) 
demonstrated how by focusing on a particular aspect of a problem (i.e. drinking and driving), 
policies shaped a certain reality of this problem that may exclude alternative framings, 
explanations, and solutions.  
The political scientist Stone (2012) criticised the so-called ‘rationality project’ that 
assumed that policies were developed by ‘rational’ and ‘analytical’ methods. She argued that 
policies were the result of struggles, conflicts and negotiations about values and definitions of 
problems and solutions. Policies were developed by continuously ‘fighting with words and by 
mobilising narrative plots, metaphors, numbers, analogies and symbols. Policy documents 
were an important actor in these fights: through articulating problems and solutions in a specific 
way, they aimed to shape specific realities and futures. According to (Asdal, 2008), policy 
documents were performative, in a sense that they not only described but also created a specific 





documents that were interconnected and co-dependent. Scholarship in the actor-network theory 
demonstrated how networks of diverse actors (including documents) both established an ‘issue’ 
and formulated rules for addressing this ‘issue’ (Asdal, 2015; Latour, 1988; Latour & Woolgar, 
1986). Therefore, these networks became obligatory passage points that cannot be avoided 
when developing new strategies for tackling an ‘issue’ formulated by a network (Callon, 1986). 
In the context of AMR, policy regulations can be seen as such a network that builds a certain 
discourse about antibiotics, AMR and OH, thus establishing an obligatory passage point in 
addressing AMR in practice. Drawing from constructivist policy approaches, our analysis of 
international policy documents on AMR focuses on the specific meanings of OH, which entail 
particular causes and responsibilities for addressing AMR.  
Methods  
Our analysis of the OH policy arena deals with two types of international policy documents 
– eleven documents dedicated to AMR and OH, and twelve documents that focus on more 
general health issues. To select the documents dedicated to AMR and OH, we first identified 
thirty-three documents that were fully or partially devoted to AMR and that were produced by 
four major international agencies – WHO, FAO, OIE, and the European Commission. Second, 
we examined these documents based on the following criteria: 1) the document was fully 
devoted to AMR; 2) it proposed recommendations/ standards for tackling AMR; and, 3) it 
incorporated OH as an approach to address AMR. From this, eight documents were selected 
for the main analysis. Third, following the same criteria, we examined references from the 
selected documents to identify other international documents that deal with AMR though the 
OH approach. In total, eleven international policy documents were included in the analysis (see 
Table 1).  
 
Table 1. Selected international One Health policy documents and EU regulations on AMR 
Title of policy documents Author(s) Year 
 A European One Health action plan against antimicrobial 
resistance 
European Commission 2017 
EU Guidelines for the prudent use of antimicrobials in 
human health 
European Commission 2017 
Global framework for development & stewardship to 
combat antimicrobial resistance. Draft roadmap 
FAO, OIE, and WHO 2017 
Antimicrobial resistance: A manual for developing action 
plans 
FAO, OIE, and WHO 2016 
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UN Draft political declaration of the high-level meeting of 
the General Assembly on AMR 
General Assembly of 
the United Nations 
2016 
Final report and recommendations: Tackling drug-resistant 
infections globally 
J. O’Neill 2016 
The OIE strategy on antimicrobial resistance and the 
prudent use of antimicrobials 
OIE 2016 
The FAO action plan on antimicrobial resistance 2016-
2020: Supporting the food and agriculture sectors in 
implementing the global action plan on antimicrobial 
resistance to minimise the impact of antimicrobial 
resistance  
FAO 2016 
EU Guidelines for the prudent use of antimicrobials in 
veterinary medicine 
European Commission 2015 
WHO Global action plan on antimicrobial resistance WHO 2015 
 
International policy documents on AMR and OH were not developed from scratch, but 
they stemmed from existing health policy discourses, initiatives, and practices. In the selected 
AMR documents, we found systematic references to more general health documents produced 
by the same organisations – the WHO, the FAO, the OIE, but also the World Trade 
Organisation (WTO), the United Nations International Strategy for Disaster Reduction 
(UNISDR), and the United Nations Environmental Programme (UNEP). These documents 
provided context and were part of the network from which AMR OH policies have originated. 
Therefore, in order to understand AMR OH policies within the context of international health 
policies and to trace a rationale in its thought style, we decided to include those general policy 
documents that focused on the health of humans, animals, and the environment in the analysis. 
In total, twelve general health documents were analysed (see Table 2).  
 
Table 2. Selected general international health documents 
Title of policy documents Author(s) Year 
Aquatic animal health code OIE 2017 
Terrestrial animal health code OIE 2017 
Bangkok principles for the implementation of the health 
aspects of the Sendai framework for disaster risk reduction 
2015-2030 
UNISDR 2016 







Sendai framework for disaster risk reduction 2015-2030 UNISDR 2015 
Operational framework for good governance at the human-
animal interface: bridging WHO and OIE tools for the 
assessment of national capacities 
WHO and OIE 2014 
Rapid risk assessment for acute public health events  WHO 2012 
One Health: Food and agriculture organisation of the United 
Nation strategic action plan 
FAO 2011 
The FAO-OIE-WHO Collaboration: Sharing 
responsibilities and coordinating global activities to address 
health risks at the animal-human-ecosystems interfaces 
FAO, OIE, and WHO 2010 
International health regulations WHO 2005 
International plant protection convention FAO 1997 




First, we double-read each document to define categories for analysis. Second, following 
our goal to understand how OH is conceptualised in AMR policies, the following analytical 
categories were established: types and kinds of relationships between human, animal, and 
environmental health; causal relations between AMR practices in the different health sectors; 
and roles and responsibilities of various professionals to control and prevent AMR. Then, using 
the NVivo 9 qualitative data analysis software (QSR International Pty Ltd, Doncaster, Victoria, 
Australia), we analysed each document in accordance with the established categories. 
Roots of One Health: general international health regulations  
Although general health policy documents are not focused on AMR and often do not 
mention the concept of OH, they play an important role in the making of OH. In order to 
become part of the international health policy network, OH regulations for AMR have to be 
aligned, in defining problems and solutions, with already established documents. Therefore, to 
better understand the content of AMR documents, in this section, we will first give an overview 
of the context in which these documents originated. In our analysis, we found four main 
characteristics of these general international health regulations.  
First, general health documents, not surprisingly, predominantly focus on improving, 
sustaining, and promoting the health of humans. Human health is understood quite broadly; as 
it involves not only the biological wellbeing but also the ‘environment, health status, 
behaviours, social or cultural practices, health infrastructure and legal and policy frameworks’ 
as factors that can shape human health (WHO, 2012). These health policies often describe 
humans as vulnerable and those who must be protected from various environmental hazards. 





For instance, one of the documents emphasises the necessity to protect humans by trying to 
‘stimulate people-centred public and private investment in emergency and disaster risk 
reduction, thus putting human health at its centre (UNISDR, 2016). 
Second, animal health is recognised as being important in two different ways. On the one 
hand, animals are understood to be a resource for human health; on the other hand, they are 
considered as potential carriers of diseases. Animal health has to be secured because threats to 
animal health may transform into health risks for humans. One of the documents stated that 
‘good veterinary governance is key to improving national productivity and income generation 
as well as contributing to human health (WHO & OIE, 2014). Another document – Frontiers 
2016 report: Emerging issues of environmental concern – raises a question about the 
consequences of inappropriate practices towards animals, such as the illegal smuggling of 
wildlife animals, which can influence human health. Although this document raises a concern 
about the appropriate behaviour with respect to animals, it mostly focuses on how misconduct 
towards animals can influence humans,  
But the attempt to smuggle an exotic animal through a major international hub only hints 
at the massive and lucrative illegal trade in live animals that threatens to decimate wild 
populations and ecosystems, even as it exposes entire cities and regions to corruption, 
violence and deadly diseases (UNEP, 2016).  
Third, as far as international health documents deal with animal health, they largely focus 
on domesticated animals. These documents are looking at human practices dealing with 
animals as part of the human food chain, such as farming and veterinary medicine, while 
pointing to the responsibility of animal professionals, including farmers and veterinarians, for 
potential human health hazards coming from the animal sector. One of the documents, for 
example, states ‘veterinarians have a dual responsibility – the epidemiological surveillance of 
animal diseases and ensuring the safety and suitability of meat (OIE, 2017, emphasis original). 
Fourth, most health policy documents do not mention how the environment affects human 
health. The notion of the environment, if it is mentioned in a document at all, is not 
operationalised, so it is quite difficult to grasp the meaning of what is understood as the 
‘environment’. The documents that do mention the environment point to the interdependencies 
between human, animal, and environmental health. One of the documents discusses 
environmental health as something both valuable in itself and important for human and animal 





for healthy living, where health is understood broadly as an ecological phenomenon. The 
notion of the environment is understood through human practices, such as agriculture, 
manufacture, and waste production, which can influence and shape a healthy environment. It 
is stated that ‘changes in the environment are usually the result of human activities, ranging 
from land use change to changing climate’ (UNEP, 2016).  
International health policy documents can be seen as providing a context for a developing 
OH framework in AMR. These policy documents are dedicated to improving human health, 
thus emphasising human exceptionalism over animals and the environment. When animal or 
environmental health is mentioned, it is often in terms of a function of human health. In the 
international AMR arena, important OH policy documents refer to and build upon these general 
health policy regulations. Analysis of these general regulations helps us to understand a 
rationale for developing international AMR documents that we will explore in the next section.  
Continuity of human exceptionalism: One Health policies to tackle AMR  
Although AMR is recognised by many international health organisations as a major 
problem that requires an OH solution, a closer look at the policy documents reveals that they 
define this problem in various ways. While some documents define AMR as a major threat for 
human health, arguing that ‘it [AMR] needs to be seen as an economic and security threat’ 
(O’Neill, 2016), other documents argue that AMR is a threat for both human and animal health. 
For instance, the EU Guidelines for the prudent use of antimicrobials in veterinary medicine 
states that ‘AMR is not only an animal health and economic concern [. . .], but is also a public 
health concern’. Other documents broaden the problem definition even further, describing 
AMR as a multispectral problem that ‘pose[s] an extraordinary threat to human and animal 
health, and to the world ecosystem’ (OIE, 2016). Different policy documents construct AMR 
differently, as either a problem of human health, of human and animal health, or of human, 
animal, and environmental health. In contrast, however, our analysis of these documents shows 
that they construct OH in a very specific way.  
First, one of the most pressing problems in the policy documents is that of antibiotic use 
in clinical health care as well as in the animal and agricultural sectors. Many documents 
emphasise that antibiotic use in clinical settings is a contributing factor to the rise of AMR in 
humans. Some of the documents make a circular link between the contamination of the 
environment with antimicrobials (that is, the result of animal, human, and manufacturing 
waste) with the potential risks of AMR transmission though the environment to humans,  





Antibiotics can reach the environment through three principal channels: animal waste, 
human waste and manufacturing waste. They can contaminate soil, crops and water 
sources and encourage the development of drug resistance amongst the pathogens with 
which they interact (O’Neill, 2016).  
Second, similar to general health regulations, AMR OH policy documents focus on human 
health, framing the causality of human-animal relations as one-directional. Humans are those 
who suffer from AMR, in terms of their physical wellbeing as well as economic prosperity, 
while animals are presented mainly as potential risk factors for human health. In the documents, 
these risks are connected to the direct transmission of resistant bacteria from animals to humans 
and to the economic losses due to animals’ illness and death from AMR. As one of the 
documents states  
[T]he overarching principle for addressing antimicrobial resistance is the promotion and 
protection of human health within the framework of a One Health approach, [and] . . . this 
requires coherent, comprehensive and integrated multisectoral action, as human, animal 
and environmental health are interconnected (General Assembly of the United Nations, 
2016). 
In other words, animal health is part of OH, but only as a means to human health. This 
implicit causal relation is also expressed in the slogan of the OIE which reads ‘Protecting 
animals, preserving our future’ whereby animals are described as a necessary element for 
human health but not vice versa (OIE, 2016).  
Third, the AMR OH world described in policy documents includes mostly domesticated 
and food-producing animals. To be sure, AMR OH policies do not consider domesticated 
animals as a threat to human health in itself, instead, they focus on human practices like the 
use of antimicrobials in farming and veterinary medicine,  
Regarding food safety, standards have been developed by the FAO/WHO Codex 
Alimentarius Commission [. . .]. They provide methodologies to appropriately reduce the 
risk of the emergence of resistance or spread of resistant bacteria through food that result 
from the use of antimicrobial agents in food-producing animals (FAO et al., 2017). 
Consequently, AMR documents assign a particular responsibility for human health to the 





of animals in accordance with the needs of human health. Therefore, the potential risks that 
human practices can pose on animals and wildlife are not widely considered.  
Fourth, similar to the general health policy documents, AMR OH regulations do not 
provide a clear definition of the environment or environmental health. Not every document 
considers the environment, and when it is mentioned the operationalisation of what is 
considered to be ‘environment’ is often lacking. Some documents refer to the environment 
including elements such as water, air, soil, as well as wildlife that can be harmed through 
human and animal practices, and that can also constitute a substantial risk for human and 
animal health,  
The environment is increasingly acknowledged as a contributor to the development and 
spread of AMR in humans and animals, in particular in high risk areas due to human, 
animal and manufacturing waste streams, but strong evidence is still required to better 
inform decision-making in this area (European Commission, 2017).  
Drawing from the international health policy discourses, policy documents that argue for 
the urgency of OH to deal with AMR globally stress, on the one hand, the interdependency 
between human, animal, and environmental health. However, on the other hand, these sectors 
are associated with each other in a very specific, asymmetrical way. OH policy documents tend 
to assign different roles to different sectors in AMR control and prevention. Humans are 
usually portrayed as those who experience the burden of AMR, while animals and 
environments are often defined as sources of this threat. In line with this, initiatives and actions 
proposed by the OH approach unintentionally reflect the asymmetrical and hierarchical 
relations between human, animal, and environmental health. AMR can be caused by different 
factors, including the use of antimicrobials by humans, clinical waste and the use of 
antimicrobials in the animal and environmental sectors, that involve farming, veterinary, 
agriculture and manufacturing. However, OH documents unintentionally frame the risks to 
human health as a driving force underlining the need for greater control and prevention of AMR 
in the human, animal, and environmental sectors (See Figure 1).  
 






Figure 1. The hierarchical structure of AMR policies.  
Discussion  
In the context of social science research on OH, we used insights from constructivist policy 
studies to analyse the specific conceptualisations of OH in the international policy arena of 
AMR. Our study makes clear that AMR OH policy documents follow the discourses present 
in general international health regulations: they put human health at the centre stage, and the 
animal and environmental sectors are presented primarily as risks to human health. Moreover, 
veterinary and environmental practices are framed from a human-centred perspective – animals 
that have not been domesticated are given minimal attention compared to livestock and pets. 
Although this framing might seem logical, as people are confronted with AMR initially as a 
human health problem, our analysis demonstrates the ambiguity of the OH policy framework 
for AMR. While the ideal of OH is presented as a collaboration between professionals from 
the human, animal and environmental sectors, this collaboration is, simultaneously but 
unintentionally, framed as hierarchical. This specific framing entails that the values of the 
human health sector prevail above the values of other non-human sectors. 
Studying how OH has been adopted in the context of international cooperation against 
avian influenza, Chien (2013) shows that this framework for collaboration has been well 
perceived by officials of international organisations such as the WHO, the FAO, and the OIE. 
She describes that the representatives of these organisations understand OH as a framework 
that can help to reduce tensions between diverse interests and expertise, and that it can help to 
build a balanced approach to a shared health concern. However, focusing on a product of inter-
organisational collaborations in AMR, which is policy documents, here we showed that the 
ideals of a balanced and unified approach have not been fully translated into the documents 





relations between organisations working in the human, animal, and environmental sectors. As 
such, OH policies do not explicitly open up or create a discursive space for exploring and acting 
upon different values that are at stake in AMR prevention.  
As we mentioned in the introduction, the ambiguous nature of OH has already been 
scrutinised by researchers like Craddock (2015), Hinchliffe (2015), and Wolf (2015). With 
Hinchliffe (2015) as well as Wolf (2015) arguing in their works that the OH framework runs 
the risk of oversimplifying and reducing the diversity of approaches and methods of various 
disciplines. Other authors highlight that OH can undermine certain values and motives of 
different sectors and local contexts (Craddock, 2015; Giles-Vernick et al., 2015; Smith et al., 
2015). Our analysis provides similar findings with respect to AMR. While OH, in theory, may 
enable collaboration between the human-, animal- and environmental sectors, its 
implementation in policy documents, runs the risk of legitimizing the unequal, hierarchical 
structure of addressing AMR in these sectors.  
The formulation of such hierarchical cooperation with human health interests at the top of 
the pyramid is in parallel with the historical discourses on AMR. Works on the history of 
antibiotics and antibiotic regulations by Bud (2007), Kahn (2016), and (Kirchhelle, 2018a, 
2018b) showed how starting from the 1930s, antibiotics became an essential part of not only 
human medicine, but also farming and agriculture. Since then, the heated debates with regards 
to the roles and responsibilities of non- human sectors in the growing issue of AMR have been 
taking different shapes – from the separation of burdens and responsibilities faced by the 
human and non-human sectors to the interrelation of these burdens and the allocation of 
responsibilities exclusively to the animal and environmental sectors. The OH framework can 
be seen as an attempt to balance these debates and to distribute the AMR burdens and 
responsibilities between and within various sectors. However, the power to give definitions 
and to make decisions with respect to burdens and responsibilities still lies within the human 
health sector.  
We can find attempts to reformulate an anthropocentric OH approach in works on post- 
humanism, for instance in Murdoch (2004) and Rock (2017) articulated that ‘human problems 
cannot be understood accurately without taking non-humans into account’ drawing attention 
to the inevitable multi-species entanglement in the understanding of health. Proponents of post-
humanism provide a critical vision on the anthropocentric structures of modern science and 
politics, drawing attention to the complexity of multi-species communities that are interlinked 
with each other (Badmington, 2004; Murdoch, 2001; Rock, 2013). In line with this, Law (2015) 
develops a critique towards a one-world metaphysics, arguing that the unification of multiple 





realities enacted in practises of various professionals silences the least dominant of these 
realities (e.g. ecological aspects of AMR). Instead, he argues, we should focus on crafting 
encounters across different practices, knowledge, and thus worlds. As opposed to the idea of a 
unified understanding of health, Law (2015), as well as Rock (2017), provoke us to rethink the 
concept of health through its multiplicity, which is exercised in the different realities of the 
human-animal-environmental sectors.  
In the network of AMR policy documents, we can see that OH discourses have been 
predominated by anthropocentric ideals. Therefore, other ontologies that might exist in the 
animal and environmental sectors are not given an opportunity to establish a politically 
legitimate understanding of AMR that would be based on their practices, knowledge, and, 
therefore, their realities. Following the way Stone (2012) and Asdal (2015) understand policies 
– as performative documents that can shape a discursive space to deliberate new routes of 
dealing with urgent public problems – we may conclude that the discursive space shaped by 
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Antimicrobial resistance (AMR) is often presented as a major public health problem 
globally. Screening for AMR usually takes place in clinical settings. Recent developments 
in microbiology stimulated a series of studies focusing on AMR in communities, and 
particularly in travellers (any mobile individual), which was argued to be important for 
identifying potential public health risks. Against this background, microbiologists have 
become interested in non-hospitalised refugees as one of the traveller groups. However, this 
attention to refugees has provoked some professional debates on potential stigmatisation of 
refugees as dangerous ‘others’. To contribute to these debates, and to explore the idea of AMR 
screening of non-hospitalised refugees from different perspectives, we conducted a qualitative 
study among four groups of stakeholders who were chosen because of their associations with 
potential microbiological screening: microbiologists, public health physicians, public health 
nurses, and refugees. The study took place in a Dutch city from June to August 2016 and had 
17 participants: five microbiologists, two public health nurses, four public health physicians, 
and six refugees. While microbiologists and public health physicians demonstrated a de-
contextualised biomedical narrative in arguing that AMR screening among non-hospitalised 
refugees could be important for scientific research as well as for AMR prevention in 
communities, public health nurses displayed a more contextualised narrative bringing the 
benefits for individuals at the centre and indicating that screening exclusively among refugees 
may provoke fear and stigmatisation. Refugees were rather positive about AMR screening but 
stressed that it should particularly contribute to their individual health. We conclude that to 
design AMR prevention strategies, it is important to consider the complex meanings of AMR 
screening, and to design these strategies as a process of co-production by diverse stakeholders, 
including the target populations. 
  
  






The ever-increasing global level of antimicrobial resistance (AMR) is often presented as a 
major public health threat, resulting in an estimated number of human deaths that will 
dramatically increase from 700,000 in 2015 to 10 million in 2050 if left unresolved (O’Neill, 
2016). AMR is defined by the WHO (2018) as an evolutionary process of development 
of microorganisms that acquire the ability to withstand antimicrobial drugs, thus making 
treatment of infections ineffective, and increasing the risk of resistant microorganisms 
spreading among people, animals, and the environment. Microbiologists cite different sources 
of the emergence and dissemination of AMR, such as misuse of antibiotics in humans, animals, 
and the environment; mobility of human populations between regions and between care 
facilities (Selgelid, 2007). 
Microbiological studies have focused on the emergence, control, and prevention of AMR 
within health practices. Scientists have studied the prevalence of resistant microorganisms in 
different groups of patients, for instance, in paediatric and intensive care units (Gaspari et al., 
2006; Khurana et al., 2017). Based on similar studies, countries have developed their national 
guidelines on the prevention of AMR in hospital settings. For instance, the Netherlands 
developed a so-called ‘search and destroy’ policy for AMR, that involves AMR screening of 
all hospitalised patients and isolation of those patients who are considered to be at risk groups 
(Kluytmans-Vandenbergh et al., 2005). Such risk groups include patients who received 
treatment in a foreign hospital within two months prior to hospital admission in the 
Netherlands, and farmers and members of their families who have contact with pigs, calves, or 
chickens (Werkgroep Infectiepreventie, 2017). 
Recently, microbiologists in the Netherlands (Arcilla et al., 2017), Sweden (Tangden et 
al., 2010), and Australia (Kennedy & Colliqnon, 2010) conducted AMR studies among non-
hospitalised populations such as international travellers (where ‘travellers’ are understood as 
people who move from one territory to another, crossing national borders regardless of the 
purpose of their travel), and showed that travel can contribute to the dissemination of resistant 
bacteria from endemic to non-endemic parts of the world (J. Penders et al., 2013). In this regard, 
since 2014, refugees have attracted the attention of microbiologists and public health 
professionals as a mobile demographic group travelling between geographic areas (de Smalen 
et al., 2016; Heudorf et al., 2016). 
Refugee studies on AMR have been conducted among hospitalised refugees upon their 
admission to clinics (Reinheimer et al., 2016; Tenenbaum et al., 2016). For example, in their 





that 61% of 143 refugees carried AMR, compared to 17% in the German population. Based on 
these data, the authors proposed that refugees admitted to hospitals be required to undergo a 
compulsory AMR screening, which entailed a departure from regular AMR control practices 
in Germany (we have to add, however, that since the end of 2016, individuals that have been 
in a refugee centre in the past two months are screened for AMR upon hospital admission in 
the Netherlands and several other European countries, including Germany). Other scientists 
have also suggested that AMR screening should be compulsory for refugees admitted to 
hospitals (de Smalen et al., 2016; Maltezou et al., 2017). Considerably fewer studies (Angeletti 
et al., 2016; Heudorf et al., 2016) have been conducted among healthy refugees (‘healthy’ and 
‘non-hospitalised’ will be used as synonyms for the remainder of the article), and therefore the 
data on the prevalence of AMR among healthy refugees is scarce. 
AMR screening involving both healthy and hospitalised refugees provoked discussions 
about vulnerability and potential stigmatisation of refugees as subjects of AMR screening 
(Walter et al., 2016). The question of stigmatisation of refugees with regards to AMR has been 
analysed by social scientists and anthropologists. For instance, in their analysis of politics of 
AMR in the UK, Brown and Nettleton (2016) demonstrate how the political discourse of AMR 
is framed in the concepts of ‘trauma’ and ‘catastrophe’. They argue that the meaning of AMR 
in British politics has been shifted from being understood as ‘biological resistance’ into 
‘resistance of economies’, creating a platform for articulation of new political discourses, 
which associate the ‘catastrophic’ threat of AMR with politics of immigration. In addition, the 
same authors, in their analysis of debates about antibiotics and AMR that take place among 
‘lay people’ on a popular online forum, showed how debates on antibiotics resistance became 
entangled with debates on public politics and personal responsibility (N. Brown & Nettleton, 
2017). AMR, they argue, provokes a moral reflection on bio-political responsibility of citizens 
for their individual immunitary practices, such as antibiotic use, hygiene, or immunisation (N. 
Brown & Nettleton, 2017). Other scholars have analysed the use of the notion of responsibility 
with regard to carriers of communicable diseases like SARS, Ebola, and HIV, transforming 
victims into agents (Wald, 2000, 2007). In her work, Wald reflects on the theory of Douglas 
(1966) who described how the dichotomy between ‘dirt’ and ‘pure’ relates to the distribution 
of power in society. Douglas explained that social order entails the construction of controlling 
mechanisms that restrict potential dangers and ‘sources of disorder’ caused by ‘others’, and the 
dirt-pure dichotomy helps to facilitate that. 
These studies show the complex relationship between health, stigma and control as a 
fruitful lens to study AMR screening among refugees as a travelling group. Discourses of 





catastrophism and responsibility for acquisition of AMR may create a potential danger that 
refugees coming from endemic areas are held responsible for disseminating resistant bacteria 
to host countries and imposing a danger upon other people. AMR screening of refugees can be 
seen as a mechanism that helps to control the dangers coming from ‘others’ who bring potential 
threats to the bacterial order of a host community. From the perspective of these studies, 
discussion about AMR screening may construct refugees not merely as people seeking asylum 
but as bodies polluted by foreign bacteria (Chandler & Hutchinson, 2016). Therefore, when 
speaking about AMR screening of refugees, it is important to analyse the complex meanings 
of such an intervention. 
Current debates regarding justification or non-justification of AMR screening among non-
hospitalised refugees take place in scientific journals between different scientists (Kempf & 
Heudorf, 2016; Walter et al., 2016). Refugees, however, do not often have a voice in these 
debates. The present article aims to fill that knowledge gap and to explore the voices of 
different professionals as well as refugees regarding the idea of AMR screening. For this 
purpose, we conducted a qualitative study involving microbiologists, public health 
physicians, public health nurses, and refugees. We explored how these four groups give 
meaning to potential voluntary AMR screening among healthy refugees, and how they consider 
the possible rationale, benefits, and harms of such screening. To be sure, when discussing AMR 
screening, we mean voluntary microbiological screening among non-hospitalised refugees. 
Although we acknowledge the complexity of the concept, for our study we opted for a broad 
definition of screening. When discussing it with participants, we spoke about AMR screening 
as a broad practice that included collection of stool samples for research and/or public health 
purposes. 
Methodology 
We studied four stakeholder groups who are already involved with health issues of 
refugees, and who potentially could be involved in AMR screening among healthy refugees: 
microbiologists, public health physicians, public health nurses, and refugees originating from 
Syria. Refugee participants included both people who had already obtained their official status 
of refugees and received their residence permits, and those who were still in the process of 
applying for asylum. The study was conducted in a Dutch city from June to August 2016. It 
involved a variety of qualitative methods, including observations of participants in their daily 
life and professional activities, in-depth interviews, group interviews, and informal discussions 





opportunity to analyse in-depth meanings that different stakeholders gave to the phenomenon 
of AMR and to the idea of AMR screening of refugees. 
Research participants 
Microbiologists who participated in the study had experience working with AMR in 
clinical (diagnosis, therapy, and prevention) and research settings, including microbiological 
screening of travellers. At the time of our study, two microbiologists were actively involved in 
developing a research proposal for AMR screening of non-hospitalised refugees in the 
Netherlands. Therefore, the interviews and discussions were of particular interest for them. 
The public health physicians and nurses have practical experience and knowledge in 
working with hospitalised patients who carry resistant bacteria, as well as experience in 
working with national AMR prevention programs. In addition, participants from these two 
groups have experience in communicating with refugees in the context of implementation of 
prevention strategies in asylum centres. It is important to note that public health physicians and 
public health nurses who participated in the study worked at the same organisation in one 
office, and therefore they knew each other and collaborated with each other on various public 
health programs. 
With regard to refugees, we chose to narrow our focus to Syrian refugees, because at the 
time of the study they comprised the largest refugee group in Europe (UNHCR, 2017). We 
collaborated with one of the master's program students from Maastricht University in the 
Netherlands, who himself was Syrian and worked as a physician in a hospital in Syria before 
his arrival in the Netherlands. His background and knowledge of the Arabic language helped 
us to build contacts with people in the asylum-seeker centres. He assisted as a translator during 
two interviews with refugees and explained language nuances. 
Qualitative study 
The study involved 17 participants: five microbiologists (two female and three male), two 
public health nurses (two female), four public health physicians (two female and two male), 
and six refugees (three female and three male). The number of participants was determined by 
data saturation. The age distribution at the year of the study among refugees was between 24 
and 60 years old, and among professionals between 35 and 63 years old. The first author visited 
microbiologists and public health professionals at their offices, and refugees were interviewed 
at asylum-seeker centres, either in their private rooms or in interview rooms. All interviews 





were conducted in English, apart from two interviews with refugees that were conducted in 
both English and Arabic at the request of the interviewees. 
All interviews were tape-recorded after written informed consent was provided, and 
participants received a copy of the consent form with the researchers' contact information and 
affiliations. Interviews were coded for anonymity and transcribed verbatim. Interviews were 
read and discussed with all authors. Based on the literature from sociology of diagnosis and 
anthropology of AMR, the first author defined categories for interview analysis that were 
relevant to the study. These categories were discussed with the other authors, and subsequently 
modified. The final analysis of the interviews was discussed with and modified by all authors. 
The process of inviting refugees to take part in the qualitative study required several steps. 
After having obtained permission to visit two asylum-seeker centres from the centres' 
administration, we visited the centres four to six times over two weeks to introduce ourselves, 
our study, and the issue of AMR to potential participants. During these weeks, we met the 
administration of the centre and refugees from various countries, not only Syria. In the next 
months, we visited the asylum-seeker centres one to three times per week. During this 
fieldwork, we heard stories about the process of immigration and the previous lives of refugees 
in their countries of origin. 
During our initial visits to asylum centres we introduced ourselves as researchers and 
approached people whom we met in communal areas, such as kitchen, common rooms with 
tennis table and TV, and communal spaces outside the buildings of the centres. Syrian refugees 
who expressed their interest in participating in the qualitative study were provided with detailed 
oral and written information about the research, and its aims and objectives. Information was 
provided in both English and Arabic. In addition to voice-recorded qualitative interviews, the 
first author conducted observations of the daily life of refugees and asylum seekers and made 
notes on the informal discussions with participants. 
After the study was completed, a report was sent to all the participants in order to receive 
their agreement or disagreement with the authors' interpretations of the data collected. We 
received feedback from all public health nurses and physicians, and four microbiologists 
provided their comments. However, none of the refugees replied to the report. One of the 
participants explained that he did not have time to read through it; another person commented 
that it was too difficult for her to read long texts in English. In addition, some of the people 
who participated in the study moved to other asylum centres or received their housing by the 






According to Dutch regulations, qualitative studies do not require a legal approval from 
an ethics committee. However, we made a decision that it was crucial that the study be 
conducted in an ethical way and therefore applied for ethical clearance. The study was 
approved by the Medical Review Ethics Committee of the Maastricht UMC+ (approval number 
METC 16-4-117.1/ab). 
Findings: understanding AMR from different perspectives 
Screening is required for prevention and research 
Both the microbiologists and the public health physicians presented AMR as an alarming 
public health problem, and therefore, generally supported the idea of AMR screening of healthy 
refugees. They provided a rather de-contextualised justification of AMR screening, arguing 
that screening of refugees entering the country can be essential for public health as well as for 
the necessity of research. In interviews, microbiologists argued that non-hospitalised refugees 
are an important and large population that cannot be ignored when it comes to potential health 
threats. 
There are so many people [refugees] coming in right now, it should not be ignored, it is 
public health and it should be studied (M2). 
It is research [AMR screening of healthy population] that has a rationale in knowing more 
about to which extent resistance is threatening us and will threaten us in the future. (M3). 
By the time the study was conducted, unless a refugee had been treated in a foreign hospital 
in the last two months before her hospital admission in the Netherlands, she did not need to 
undergo obligatory screening for AMR. Public health physicians argued that the AMR study 
among non-hospitalised refugees would help to determine whether refugees should be added 
to the category of a risk group for obligatory AMR screening during their admission to a 
hospital regardless of whether they were in a foreign hospital before. 
It is useful to have some background information about the risk levels within our 
community, or within our region. … If we find that AMR is high in refugees that would 
necessitate hospitals to deal with them in the same way as with people who spent some 
time abroad or who were admitted to a hospital in a foreign country – isolate them, screen 
them, and treat them if necessary (PHD3). 





In addition, microbiologists pointed out that AMR studies among healthy populations, 
including refugees, could be important for developing scientific knowledge in the field 
of microbiology. 
The data not primarily used for the participants [healthy populations], it primarily used to 
get further in the professional field. And that is something which also has to be considered, 
which research should be done which is good for the professional field. (M3). 
While the participants came up with a biomedical justification of AMR screening of 
refugees and do not refer to political issues, social scientists have demonstrated that this 
distinction between science and politics is difficult. Brown and Nettleton (2016) described how 
in the mid-2000s in the UK, conservative politicians were trying to lobby a policy that would 
impose ‘compulsory screening of migrants prior to departure from their countries of origin’. 
Such policies, as the authors emphasised, merge discourses of bio-politics of race with those 
of infectivity, thereby stigmatising newcomers as dangerous, and shaping the image of AMR 
as a threat coming from the outside. 
Although ideas about the scientific rationale for AMR screening of healthy refugees were 
widely accepted by microbiologists and public health physicians, not every interviewee agreed 
with them. One of the microbiologists, who was working as an internist in infectious diseases, 
was not particularly convinced about the potential clinical benefits of AMR screening of non-
hospitalised refugees. While he agreed that the data from such screening might be interesting, 
he emphasised that it was hard for him to see why microbiological screening of healthy 
refugees would be necessary. 
When there is no problem [when refugees are healthy], well, it's a lot harder for me to see 
the importance of screening. Because why should you screen, there is no problem there. 
No, there is no problem there. Maybe you might screen them just as a baseline. For 
example, we do not know anything about refugees and about antimicrobial resistance 
prevalence so you want to know at the baseline what is actually the prevalence 
of antimicrobial resistance among healthy refugees. When it is 0, then we do not have to 
be afraid, but when it is 80%, maybe we have a problem there. So for research, maybe it 






However, the same participant indicated that microbiological screening of healthy populations 
who are not refugees might be beneficial for public health in general and clinical practice in 
particular. 
With regards to the screening of the healthy population, well, I think we all want to better 
understand, for example, how resistance is transmitted. Is it taken from abroad and then 
introduced for example to the Netherlands? And how is it, by hand contact, or by faecal 
contamination, or by air? You can think of all kind of things. So I think when you want to 
fight against antimicrobial resistance and you see that as a problem, I think it is really wise 
to understand how does it really spread among the population. And one way to look at it 
might be to screen healthy volunteers who have travelled all over the world, and screen if 
they carry antimicrobial resistance bacteria. (M5). 
One of the limitations of AMR screening among healthy refugees that was mentioned in 
the interviews was the lack of any personal benefits for participating refugees, because there is 
no treatment for resistant bacteria in healthy people. The screening may, for instance, indicate 
that a healthy refugee carries the β-lactamase gene, but this knowledge will not benefit her, as 
she cannot be treated for it. One of the microbiologists explained this difficulty while talking 
about the AMR study conducted with international travellers: 
We screened them [travellers] for antimicrobial resistant bacteria in gastrointestinal tracts 
of healthy subjects basically, and if a person is positive, we know that. Before travel 6% 
of the travellers were positive, when they came back, 34% were positive so there was a 
huge increase. But we cannot do anything with that, we can only tell them that you have 
antimicrobial resistant bacteria and that's it, people don't have any benefits from it, there 
is no treatment from it, there is also not any harm as far as we now know as long as they 
are healthy. … We were very reluctant in telling people whether they are positive for 
antimicrobial resistant bacteria, we did not want to worry them … We really think it was 
not very wise to scare people with something. …. Then we decided not to communicate 
results individually to people. (M2). 
However, other microbiologists and public health physicians emphasised that the decision to 
not report individual results back to participants might also be problematic, because people 
often want to know their data. Emphasising this complexity, one of the microbiologists 





described how she herself felt uncomfortable not knowing her individual results from the AMR 
study in which she participated. 
We are mainly studying resistance in the total community, so also in common cells, so we 
are saying to also the people that help us in the study, and to participants, that we don't 
really know yet what it means if you have this. And of course, I mean, like I participated 
in some of our own studies as well and all of a sudden, you know, then you start wondering 
like, ‘Hmm, do I have a resistance in me or not?’, you know. It is, it is just strange, what 
does it mean and I tell everyone, ‘Oh, it does not mean anything, we do not know, we have 
not seen any evidence yet that you have more risk of infection’, but still when it was all of 
a sudden, when it was about me, I thought, ‘Hmm, I actually want to know if I have or not 
have it.’ So yes, but in general, since we do not know what it means we do not report it 
back to people. (M1). 
Microbiologists understand that while the technology of screening may provide them 
insight in the bacterial world of a healthy person, it does not give them an instrument to control 
this world. In this context, AMR screening of healthy individuals reveals unruly ‘intolerant 
bodies’ that pose potential risks to these persons themselves and to others (Anderson & 
Mackay, 2014). Both microbiologists and public health physicians emphasised that the 
knowledge from AMR screening can be used in developing medical guidelines for healthcare 
practice, and they generally expressed support for the potential AMR screening of healthy 
refugees. The arguments for such screening are rooted in a de-contextualised biomedical 
discourse that does not anticipate the contextual risks of associating refugees with AMR. 
Screening is not fruitful for healthy persons 
As opposed to the discourse of microbiologists and public health physicians, public health 
nurses expressed a more personal and contextualised orientation to AMR, and they were 
hesitant about the idea of AMR screening of healthy refugees. They doubted whether such a 
study could bring any benefits to refugees, and whether possible public health benefits 
outweighed personal considerations. Public health nurses argued that microbiological 
screening would only stimulate worries among refugees about their health status as well as 
uncertainties regarding the screening itself, because AMR is not a common medical concept. 
According to nurses, AMR screening is a technique that is used in hospital settings, but one 





The population is not ill at the refugee centre; there is no need to do screening. It [AMR] 
does not do anything with healthy people. … If you test them at refugee centre, what would 
you do? You can't do anything with this knowledge, you can't treat them. (PHN1). 
Public health nurses who participated in our study always worked with individuals (e.g. 
for STD or TB testing), and they had experience as nurses in hospitals, as well as in providing 
AMR training for nurses, and in providing educational programs about AMR in secondary 
schools. The direct interactions with diverse publics may explain why they were rather negative 
about the idea of offering microbiological screening to all refugees for public health purposes. 
Based on their experience of educating laypeople about AMR, public health nurses expressed 
that the lack of knowledge about AMR among the general public can cause prejudice, hostility, 
and stigma toward people with AMR or groups that would be offered AMR screening. They 
argued that this could particularly affect refugees, who are already presented by many media 
channels as dangerous others. This worry is mirrors the understanding of stigma as fear of 
otherness and ‘anomaly’ (Douglas, 1966; Goffman, 1968). As Douglas (1966) points out in her 
analysis of the notion of dirt, societies marginalise people if they have been in contact with 
unknown ‘danger’. In the context of AMR, this danger comes from resistant microbes. 
However, as microbes are embodied within bodies of people, they transform carriers from 
being ‘victims’ of microbial activity to ‘agents’ that represent bacteria-host relationships 
(Wald, 2007). One of the examples given was about a boy with AMR who had problems with 
going to a school for people with disabilities because he was claimed to be dangerous to other 
children. 
One child who has MRSA [resistant bacteria], and he is going to new school and there is 
some rumours, some negative excitement about it in the school. Really, really bad. It is a 
school for children who are disabled, and some people worried a lot about consequences 
of MRSA for other people and for themselves. (PHN2). 
Moreover, public health nurses emphasised that there is a lack of knowledge about AMR 
among nurses in hospitals who often do not fully understand what AMR means and why some 
actions must be taken, for example, isolating patients with AMR: 
When I was a nurse in the hospital, I just got the instructions that this is the person with 
MRSA, here is your coat, and your gloves, and your mask. But they did not explain to me 
really what the point was, I was a bit concerned that if it is MRSA, then I have to be very 





careful, and I was tested afterwards if I was clean or not. But they never explained to me 
well why I had to do it, I just did it very carefully because I was scared. And it is also stress 
for the patient because even the nurse can't explain him why these measures are taken. 
(PHN2). 
With this background of communicating with different patients who carry AMR and must 
be isolated in hospitals, public health nurses applied more contextualised approach to patients 
and potential volunteers in AMR screening. When speaking about the idea of AMR screening 
of refugees, they were focusing not merely on public health benefits, but rather on the 
complexity involved in the concept of AMR. They point to the lack of familiarity with AMR 
among both patients and nurses and the potential for provoking fear among both refugees, who 
are not able to do anything about their AMR status, and the general public, who may perceive 
refugees as carriers of dangerous microorganisms. 
What kinds of benefits does it bring us? 
All refugees who participated in the qualitative study had been living in the Netherlands 
for at least six months. All participants came to the Netherlands through Turkey and Italy, 
travelling from Italy to the Netherlands by train or car. Two of the participants had a high 
school education, and another four had either finished higher university education or not yet 
finished (because of the war in Syria). 
The phenomenon of AMR was introduced to refugees in two steps. First, we had informal 
conversations in small groups in both English and Arabic about AMR, its causes and possible 
health consequences for a person with resistant infection. Then, written information in both 
languages was provided. Most of our participants had never heard the English term 
‘antimicrobial resistance’ before; however, some of them were familiar with its Arabic 
analogue. They explained that AMR is a bodily condition that relates to the ability to fight a 
disease. 
Antimicrobial resistance is a resistance of your body against microbes, if you have 
enough white blood cells your body will fight the disease, but if you have less white blood 
cells you have immune deficiency and your body will not fight the disease. (R5). 
Another person elaborated the reasons for AMR by making a connection between the 





In Syria we take a lot of antibiotics. So maybe the genes they have immunity for this 
medication. … Because we take a lot of antibiotics in Syria, our body gets used to it. So 
how much stronger from antibiotic [no matter how strong the antibiotic], it will not affect 
us. (R1). 
At the same time, refugees argued that they had to consume antibiotics anyway because 
they help in treating diseases. One participant explained that although he understood that 
overuse of antibiotics may harm his body, he still wanted to use them because it can help 
alleviate pain. Such idea, as they explained it, is rooted in practices that people followed in 
Syria, where they could access and use antibiotics whenever they thought they were needed. 
In our country, we were taking antibiotics when we had something, or even a small pain 
in our body. (R4). 
This way of understanding antibiotics as something essential for healthy living is not 
unique. Scientists in anthropology use the metaphor of ‘charm’ to describe how different 
people understand this medicine as ‘magic bullets that have the power to heal (Chandler & 
Hutchinson, 2016). Unwanted effects of antibiotics, such as AMR, are either unknown or 
deemed to be unimportant in comparison with the treatment capacity of the drug. The Dutch 
system of antibiotic regulation was foreign to our participants who arrived from Syria. They 
preferred to consult their pharmacists instead of general practitioners, and to buy medications 
directly from a pharmacy while avoiding medical consultations. 
Our pharmacy is our own doctors … I hate Dutch hospitals because when you call them 
they tell just to take paracetamol. … Paracetamol will not make any difference if you are 
sick. Some people in Syria take antibiotics every day for headaches, most people have 
headaches. (R2). 
When discussing the idea of AMR screening among healthy refugees, some participants 
were rather positive about potential participation, because they considered participation in 
screening as a way to get more insights into their personal health problems and to get advice 
that would help them to maintain their health. 
It [screening] would be helpful for me, I can take care about myself. If there is something 
bad with me, the researcher will tell me. (R1). 





It [screening] will be helpful to take care of myself if there is any problem. So it is good 
for me. (R2). 
One of the participants explained that potential AMR screening is an important preventive 
health measure for individuals, and thus he would like to participate in it: 
If person has something wrong they [researchers] try to fix it, they are trying to make him 
better. … Research is for the person. They will do research to know what medicine is good 
for the person. … If someone has something not good they will try to get him better, to get 
him in a hospital, it [screening] is better for us. (R1). 
People participating in our qualitative research considered it necessary that potential 
information obtained through the AMR screening be shared with them and that it should benefit 
them. They pointed out that the practices of antibiotic use in their home country were the only 
ones that they knew and believed to be right, but they argued, if these practices may actually 
harm them, researchers must tell them and share their knowledge about better practices. 
You should tell us what to do to make us feel better without taking antibiotics, because I 
don't know how. (R4). 
We also explored concerns and worries about potential harms of AMR screening. When 
we discussed general medical checks that refugees are required to undergo upon their arrival 
in the Netherlands and the possibility of voluntary microbiological screening, it became clear 
that people felt a little awkward: One person said: ‘We are clean, really’ (R2). Another person 
mentioned: ‘… do not tell the media about it [AMR screening]. Because if you tell the media, 
media will tell it all wrong’ (R1). In this context, all Syrian interviewees questioned why 
potential AMR screening was discussed only with respect to refugees. They argued that if this 
screening has important health benefits, it must be offered to everyone and not exclusively to 
refugees. One of the participants raised a number of questions about the rationale of offering 
AMR screening exclusively to refugees. 
What will affect me, what will I have, what the benefit from it on me, does it help me, does 
it help all the refugees, is there anything wrong, did you suspect something, I have all these 
questions. So, did you suspect something from me as a refugee, why you are doing this 





Some people worried that if they showed some signs of a serious health problem, their asylum 
applications would be rejected. In fact, one of the refugees was reluctant to ask for medical 
assistance for her son before they arrived to the Netherlands. 
My son [4 years old] had a very high temperature [during their travel to the Netherlands], 
but I had medicines with me. Also, you know, when we had a problem, we were afraid to 
go to the doctor because we have to arrive to Europe without any problems. … So I just 
gave him some antibiotics, he felt better, and we continued. (R4). 
The refugees with whom we spoke demonstrated a complex narrative about AMR 
screening. They consider the benefits of screening for public health, but they also add that then 
AMR screening should be offered not only to refugees but to other travellers as well. They also 
consider the benefits of AMR screening for the individual health of refugees, but they express 
fears that promises of anonymity will be broken and that results of AMR screening could affect 
their asylum applications in a negative way. 
Discussion and recommendations: complex narratives about health, stigma and 
control 
The purpose of our study was not to judge which perspective on microbiological screening 
of healthy refugees was the most scientifically sound or ethically justifiable. Instead, our aim 
was to understand how different stakeholders give meaning to AMR screening, and how they 
understand ‘proper’ AMR screening of healthy refugees. 
It is important to note some limitations of our study. First, the study involved a small 
number of participants – 17 people. However, this allowed us to make an in-depth analysis of 
the complex narratives of the participants. Second, we decided to focus on four stakeholder 
groups who may be actively involved in the process of AMR screening of healthy refugees, 
although the spectrum of perspectives on this issue can be broader. Third, we deliberately 
involved only English-speaking refugees who had experience of direct communication with 
Dutch health professionals, although it excluded other potential participants who might have 
different perspectives on AMR and AMR screening. In addition, as was emphasised at the 
beginning of the article, our study was focused on voluntary AMR screening, because 
microbiological studies are currently at the stage of studying the prevalence of AMR among 
refugees. However, if microbiological screening demonstrates a high level of AMR among 
refugees, it is probable that obligatory AMR screening will be recommended for this group. 





Therefore, we would like to elaborate that further studies and ethical reflections on the potential 
stigmatisation are important in this developing field. 
While biomedical discourses about AMR tend to distinguish the scientific insights about 
AMR from the political issues, social scientists have shown that AMR discourses are more 
complex and that symbolic meanings about purity and danger, and self and others are 
intertwined with AMR policies and practices (N. Brown & Nettleton, 2016; Chandler & 
Hutchinson, 2016). Our study shows that stakeholders engaged in discussing AMR screening 
among refugees express different perspectives: we found a narrative about screening that 
emphasises the problem of AMR and the benefits for science and public health, but also 
narratives that articulate the ambiguities of screening healthy refugees, pointing to the health 
benefits for refugees and communities as well as to the risks of stigmatisation and exclusion. 
When discussing making AMR screening of healthy refugees a national or European practice, 
it is important to realise that policies are always developed in concrete contexts where complex 
narratives are operative. 
Following the work of Fleck (1979) on thought styles and thought collectives, B. Penders 
et al. (2009) argued that different thought styles also produce different notions of ‘proper’ 
science. From this perspective, we can interpret the different perspectives of the stakeholders 
as reflecting different thought styles, different practices, and different notions of ‘proper AMR 
screening’. For microbiologists as well as for public health physicians who worked mainly with 
public health issues on the level of the laboratory and statistics, the crucial argument for 
screening was the potential threat of AMR to the community and the opportunity for 
monitoring on a population level. For them, this could be done anonymously, and the subject 
of screening with her social status, cultural background and political affiliations may be 
unknown. The practice of public health nurses, on the contrary, entails meeting and caring for 
individual patients. Therefore, they considered AMR screening to be important on the level of 
detecting personal health risks, not merely on the statistical level of public health. From this 
perspective, AMR screening of healthy refugees was not considered fruitful. At the same time, 
Syrian refugees saw AMR as a bodily, personal health condition that affects people when they 
are ill but that could be prevented if a person has appropriate information about, for instance, 
antibiotic use. From this perspective, the refugees could see the benefits of screening of healthy 
refugees, but only when the results will be made beneficial for broadening AMR screening to 
larger populations. 
These different perspectives on proper AMR screening that stem from different everyday 





tragedy of the commons’. Whether AMR is recognised as a public or a personal problem would 
require putting either the community before an individual or vice versa (Foster & Grundmann, 
2006; Hardin, 1968). Various studies have demonstrated that professionals in the medical and 
public health fields have different ideas about this dilemma and give preference to either 
personal health (Broom et al., 2014; Metlay et al., 2002)or public health (Oczkowski, 2017). 
However, our study suggests that the debate about potential AMR screening among healthy 
refugees should not only consider prioritising an individual or society, but also how eventual 
AMR screening of a healthy population is framed and organised. In that respect, the input of 
the refugees is illuminating. While they demonstrated a belief in antibiotics as ‘magic bullets’, 
they also argued that they would like be informed about their individual AMR status and 
potential ways to protect their health (such as proper intake of antibiotics). Moreover, refugees 
stressed the importance of framing AMR screening among healthy refugees in a non-
stigmatising way, for instance by labelling it ‘AMR screening among travellers’ instead of 
‘AMR screening among refugees’. 
Science and Technology Studies (STS) (Jasanoff, 2004; Rabeharisoa & Callon, 2004) 
stresses that production of knowledge and technologies requires co-production of science and 
society. More specifically, Oudshoorn and others have demonstrated that ‘users matter’ 
(Oudshoorn et al., 2004; Oudshoorn & Pinch, 2003): interaction with diverse users is crucial 
for designing and developing robust knowledge and ‘working’ technologies. Several studies 
have emphasised that co-production requires constructing a dialogue and interaction between 
different styles of practices that in turn may lead to the creation of new collective identities 
around a particular issue (P. Brown, 1992; Rabeharisoa & Callon, 2004). Because public health 
has developed as a policy-driven field that is dominated by epidemiology, it has difficulty 
relating to diverse publics (Horstman, 2013). The lessons of STS are highly relevant for this 
field. Our study can be considered a first step toward co-production around the discussion of 
AMR screening of healthy refugees. Instead of assuming what is scientifically or ethically 
proper AMR screening, we explored thought styles and practices among different actors, 
because the making of scientifically, socially, and ethically proper screening depends on 
collaboration and dialogue between these actors. Instead of relying only on technical experts, 
including the voices of others reminds us that the tragedy of the commons is not an immutable 
problem, but is one that can be shaped and reshaped through engaging diverse actors 
representing different styles and practices in processes of co-production. 
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Antimicrobial resistance control programmes often aim to ‘fix’ the behaviour of antibiotic 
users and prescribers. Such behavioural interventions have been widely criticised in social 
science literature for being non-efficient and too narrow. Drawing on these critics, this article 
analyses how the political programmes for fixing antibiotic behaviour were adapted in practices 
of healthcare professionals and patients in Russia. In 2018 we conducted interviews with 
medical doctors, pharmacists and patients in a Russian city, focusing on their practices around 
the policy requirement for obligatory medical prescriptions of antibiotics introduced in 2017. 
We conceptualised the obligatory medical prescription as a political technique that aimed to 
change practices of self-treatment and over-the-counter sales of medications by establishing 
doctors as obligatory passage points to access antibiotics. Our analysis shows that the 
requirement for medical prescriptions has not reflected the infrastructural gaps that influence 
antibiotic practices. These gaps include a lack of medical specialists, long wait times for 
medical appointments and difficulty for patients to take time off work to go to the hospital. To 
compensate for these infrastructural gaps, healthcare professionals and patients adopt informal 
networks of antibiotic care within the requirement for an obligatory prescription. 
 
  






Control and regulations of antibiotics in healthcare, including prescriptions, over-the-
counter sales and self-medication, have been a priority for national and international 
programmes for addressing antimicrobial resistance (AMR) (Chandler, 2019; Will, 2018). In 
the Global Action Plan, published in 2015 by the World Health Organisation, the World 
Organisation for Animal Health and the Food and Agriculture Organisation of the United 
Nations, individual behaviour regarding antibiotic use is considered to be one of the leading 
causes of AMR. Following the international lead, national policies against AMR have focused 
on the reduction of ‘unnecessary use’ of antibiotics in healthcare (European Commission, 
2017; O’Neill, 2016). The behavioural focus of AMR policies has been scrutinised by various 
social scientists who highlight their narrow capacity and limited effectiveness (Haenssgen et 
al., 2018; Pearson & Chandler, 2019). Scholars like Chandler (2019) and Will (2018) argue 
that it is necessary to understand the underlying social, economic and political processes that 
influence antibiotic practices, rather than focusing on the individual behaviour of users. 
Despite this critique, behavioural interventions have continued to play an essential role in 
AMR control programmes (Broom, Kenny, Prainsack, et al., 2020). To understand what kind 
of work these interventions perform in the world of healthcare, we studied practices of medical 
doctors, pharmacists and patients in a Russian city. The Russian context is especially 
interesting because AMR is a relatively new object in the policy agenda of this country, and 
over-the-counter sales of antibiotics became strictly prohibited only in 2017 (Government of 
the Russian Federation, 2017). This means that our research was conducted in a context of 
policy changes that were aiming to influence antibiotic practices. In particular, we analysed 
how practices of medical doctors, pharmacists and patients have been adapting to the 
introduction of an obligatory, standardised antibiotic prescription as part of the national action 
plan against AMR that was introduced in 2017. Contributing to discussions on behavioural 
interventions against AMR, we will analyse the obligatory, standardised medical prescription 
in Russian healthcare as a political technique to manage antibiotic behaviour of heterogeneous 
actors.  
Below we will introduce the theoretical background of our study. Then, we will describe 
our research setting and methodology. In the results, we will present the analysis of how 
obligatory medical prescriptions mediate the practices of doctors, pharmacists and patients in 
a Russian city. In the discussion, we will reflect upon the findings in the context of current 






Behavioural interventions, including awareness campaigns for healthcare professionals 
and patients and practices of antibiotic surveillance and control over individual behaviour, have 
been deliberately scrutinised by social science scholars. The research conducted by Pearson 
and Chandler (2019) in Ethiopia, India, Nigeria, the Philippines, Sierra Leone and Vietnam 
demonstrates that awareness about AMR among healthcare professionals does not 
automatically translate into the reduction of antibiotic prescriptions. The authors show that 
despite the awareness about AMR, healthcare professionals prescribe antibiotics due to 
infrastructural constraints, such as lack of diagnostics and shortages of medical staff, and social 
constraints, such as economic access to antibiotics and overall level of hygiene and sanitation 
in communities and clinical settings. Pearson and Chandler (2019) argue that rather than 
reducing antibiotic prescriptions, high levels of awareness about AMR among healthcare 
professionals has given them confidence in prescribing broad-spectrum antibiotics, which are 
believed to be more effective in a setting with poor hygiene and limited diagnostic capacity.  
In a special issue of this journal, Will (2018) scrutinises individual behaviour interventions 
as a solution for AMR, and she argues for the need of a more nuanced understanding of the 
‘routines and logic’ that shape organisations and delivery of care. She elaborates that the 
antibiotic prescription behaviour of medical doctors can be influenced by multiple processes, 
including their relationships with particular patients, the socio-economic status of these 
patients, their communication with colleagues and their feelings of responsibility towards an 
individual patient and society as a whole. Following criticism of the behavioural approach to 
AMR, Chandler (2019) argues that the focus on behavioural changes tends to overlook 
infrastructural conditions that often shape the behaviour of antibiotic users in a particular way. 
She elaborates that the question of antibiotic use is not a simple, rational question of choice 
and availability of knowledge, which is often argued by behaviour-oriented policies, but 
depends on larger infrastructural processes that define social, economic and political inequities. 
Case studies from different parts of the world demonstrate how antibiotic practices are the 
results of multiple processes, including the availability of particular infrastructures to which 
professionals and laypeople have to adapt. Studying the social world of urban Australian 
hospitals, Broom et al. (2014) show that AMR as such does not play a significant role in clinical 
decision-making. Rather, doctors make their decisions about antibiotic prescriptions following 
the ‘rules of the game’ within a hospital. These rules can reflect professional hierarchies 
between more- and less-experienced doctors and a constant negotiation of immediate clinical 
risks versus long-term population burdens. In a similar study in a rural Australian hospital 





Broom et al. (2017) show that doctors have to adapt their prescription practices to the social 
and infrastructural realities of the rural area. This includes high mobility of patients who come 
to rural areas for seasonal work and large distances between a hospital and residential areas, 
conditions that challenge the continuity of treatment and stimulate prescriptions of antibiotics. 
Another study in Australian healthcare shows that inter-professional relationships between 
doctors and pharmacists can also contribute to antibiotic practices, including the informal 
negotiations about the appropriateness of a particular treatment (Broom et al., 2015). Several 
studies state that antibiotic prescriptions can be influenced by the intricate relationships 
between a doctor and a patient and between a pharmacist and a patient (Broom, Kenny, Kirby, 
et al., 2020; Cabral et al., 2015; Lambert et al., 2019). Depending on how healthcare 
professionals perceive the expectations of patients, they may feel obliged to prescribe or sell 
antibiotics to preserve a trusting relationship with a patient and to provide a physical symbol 
of care in the form of a prescription.  
Antibiotic practices of patients can also be influenced and shaped by different processes, 
beyond immediate knowledge about AMR. In her study of self-medication practices in Maputo, 
Mozambique, Rodrigues (2020) analyses the different rationales of patients for using 
antibiotics. She argues that communication between healthcare professionals and patients plays 
an important role in patients’ decisions for self-treatment. She shows how standardised 
practices of diagnosis and treatment exercised by doctors become familiar to patients. After 
visiting a doctor several times with reoccurring complaints, patients become acquainted with 
medical practices of diagnosis and treatment, including medical prescriptions. As a result, 
Rodrigues (2020) shows, by learning the practices of doctors, patients feel confident enough 
to perform self-treatment with medications that were previously prescribed to them. 
Another study on antibiotic use behaviour among patients was conducted by Willis and 
Chandler (2019) with participants from Tanzania and Uganda. The researchers show that these 
behavioural practices are influenced by structural dimensions. These dimensions include 
limited access to non-pharmaceutical forms of care, economic demands for productivity and 
thus inability to sufficiently convalesce after an illness and poor sanitary conditions in certain 
settings, which require people to use antibiotics for prevention. Willis and Chandler (2019) 
argue that within these dimensions antibiotic use can be understood as an attempt to quickly 
‘fix’ access to care, individual productivity and poor hygiene.  
In these various settings, researchers have highlighted the importance of analysing 
antibiotic practices as influenced by diverse social, political and economic processes. This 





antibiotics have become an invisible steering wheel for guiding the understanding of health, 
hygiene and permissible time for illness and recovery. The analysis of antibiotics as 
infrastructural was proposed by Chandler (2019) to highlight how antibiotics are embedded 
into the different spheres of modern living, defining hygiene as non-bacterial, healthcare as 
based on pharmaceutical care and productivity as not disrupted by prolonged illnesses. AMR, 
she argues, is performing an inversion of these infrastructures by challenging conventional 
practices of antibiotic use and making visible the dependencies between these medicines and 
modern ideas of health and productivity.  
Grounding our research in these theoretical insights, we will analyse obligatory medical 
prescription in Russia as part of the antibiotic infrastructure that organises modern ways of care 
delivery. Focusing on practices of medical doctors, pharmacists and patients, we will entangle 
this infrastructure and make visible practices and dependencies that antibiotics create in 
Russian healthcare.  
AMR, antibiotics and Russian healthcare  
Following the global movements in developing national plans to tackle AMR, in 2017 
Russia launched its national strategy to prevent the spread of AMR lasting until 2030. Similar 
to the Global Action Plan on AMR, the Russian strategy highlights the importance of tackling 
the misuse of antibiotics in healthcare practice, articulating the need for behavioural changes 
among antibiotic users and prescribers. Since 2017, the federal government has introduced 
several changes into the federal regulation on drug circulation (Federal law №61). In particular, 
surprise inspections (i.e. unplanned and unnotified inspection of a pharmacy) have been 
implemented to enforce control of the over-the-counter sale of medications, including 
antibiotics, in pharmacies (Federal law №61, Article 9). In addition, pharmacists have been 
obliged to collect and file patients’ prescriptions for inspection purposes (Decree N 647н). 
Although there has been a prohibition on the sale of antibiotics without a prescription since 
2006, there were no mechanisms to control this regulation. The introduction of surprise 
inspections and the requirement to collect and file patients’ prescriptions in a pharmacy in 2017 
restricted the over-the-counter sale of medications and thus enforced patients to seek an official 
standardised prescription from a medical doctor. 
The Russian healthcare system has often been characterised by informality (Temkina & 
Rivkin-Fish, 2019; Zvonareva et al., 2018). This informality is rooted in different types of 
personal relationships between a patient and a doctor and between a patient and a pharmacist. 
These relationships can be both financial and economic (non-monetary presents) or based on 





friendship and favours. In contrast to the Soviet Union, where private payments for healthcare 
services were not allowed, at the beginning of the 1990s, while preserving the principle of 
universal free-of-charge healthcare by introducing compulsory medical insurance, Russia 
legalised some private payments for various health services. However, official channels to 
distribute these legal payments from a hospital’s administration to doctors and nurses were 
often distrusted. In this context, informal payments to doctors and nurses started to play an 
important symbolic role in establishing trusting and caring relationships with a particular 
doctor (Cook, 2014; Rivkin-Fish, 2005).  
By the late 2000s, informal payments in Russian healthcare dropped significantly – the 
number of people who informally paid for diagnostic services decreased from 36% in 2001 to 
17% in 2011 (Shishkin et al., 2014). Shishkin et al. (2014) explain this drop by referring to the 
launch of the national priority project Health, implemented in 2006, that included a salary 
increase for medical professionals and legalisation regarding various pay-for-service practices 
which, before, were conducted under the table. Although informal payment practices 
decreased, Temkina and Rivkin-Fish (2019) argue that contemporary Russian healthcare 
preserves part of its informal organisation. Despite the liberalisation of the healthcare provision 
that allows patients to choose free or paid medical services, patients continue to rely on 
personal networks for establishing trusting doctor-patient relationships.  
Methodology  
To understand the work of obligatory medical prescription of antibiotics in healthcare 
practices, we conducted a qualitative study of the daily antibiotic realities of doctors, 
pharmacists and patients. To that purpose, we engaged five types of doctors from different 
specialities: general practitioners (GPs), paediatricians, ENTs, gynaecologists and urologists. 
Being a part of primary care settings, GPs and paediatricians are in continual contact with 
communities, which make them primarily responsible for providing information about 
antibiotic treatments and AMR to patients. In addition, they play a vital role as gatekeepers 
who refer patients to specialised doctors in case more intensive treatment is necessary. At the 
same time, ENT, gynaecology and urology are among the medical specialities where the most 
antibiotics are prescribed. All doctors involved in this study had been working in state 
polyclinics and primary care institutions. 
We included pharmacists as it is a common practice in Russia to go to a pharmacy for 
medical consultation instead of going to a doctor, and pharmacists play an important role in 





2020; Strachunsky and Andreeva 2004). All pharmacists except one who took part in the study 
were employed by private organisations as they constitute the majority of the pharmacological 
market in Russia.  
Patients were engaged in the study to understand how the requirement for a standardised 
medical prescription of antibiotics has or has not influenced their treatment practices and their 
relationships with doctors and pharmacists. All patients that participated in the study were in 
the process of treatment with one of the medical specialists that were included in the study. 
The study took place in a Russian city of medium size between June and August of 2018. 
To understand antibiotic practices, we conducted semi-structured interviews. In total, we 
conducted 53 interviews: 21 interviews with the doctors – five GPs, four paediatricians, four 
ENTs, four gynaecologists and four urologists. The age of the doctors who participated in the 
study varied from 25 to 60, and only three were men, which reflected the gender distribution 
of doctors in Russia. The average number of years of experience for doctors was 19.5. We 
conducted interviews with 16 pharmacists; their age varied from 21 to 47, and only one was a 
man. The average number of years of experience for pharmacists was 14. We conducted 16 
interviews with patients, and their age varied from 21 to 78; three of them were men. From 16 
patients, seven were mothers of paediatric patients. The number of interviews conducted was 
determined by data saturation. All interviews lasted between 15 and 60 minutes.  
Analysis 
To recruit doctors and pharmacists for interviews, we sent letters with information about 
the study to several primary care settings and pharmacies in one Russian city. For those doctors 
and pharmacists who responded to the call, we provided further details about the aim and 
methods of the research and obtained informed consent from participants who agreed to give 
interviews. Patients were recruited from the waiting rooms of the polyclinics. They were 
provided with detailed information about the study (aim, methods, researchers, their contacts 
and affiliations). Those patients who agreed to take part in the study signed informed-consent 
forms. In the case of paediatric patients, parents were invited to take part in the research.  
All interviews were conducted in a private space and were subsequently anonymised. 
Questions in the interviews were developed by the transdisciplinary team of sociologists and 
medical doctors, different questions were developed for the three groups of participants and 
pilot interviews were conducted with each of the group. Pilot interviews were not included in 
the analysis. All interviews were voice-recorded and transcribed verbatim. The language of the 
interviews was Russian; quotes in the article were translated into English by the first author. 





Thematic analysis was used on the transcripts of interviews. Different themes were determined 
for the three groups of participants. Each transcript was carefully analysed line by line and 
separated on themes using the qualitative data software NVivo 9 (QSR International Pty Ltd, 
Doncaster, Victoria, Australia). 
Ethical clearance  
The study was approved by the ethical committee of the Siberian State Medical University 
in Russia (№5916 on 22 May 2018). 
Results 
‘We cannot always provide quick care’ 
With the new antibiotics policy of 2017, medical doctors became an obligatory passage 
point for accessing antibiotics. The requirement for a standardised medical prescription can be 
seen as a re-articulation of the clinical authority of medical doctors over pharmacists, who were 
then restricted to providing antibiotics by prescription only. The requirement for a medical 
prescription can be seen as an attempt to regulate the professional distribution of 
responsibilities to those who prescribe and those who sell medications. Some of the doctors 
reflected on this work of medical prescription:  
L101: It is very good [that antibiotics can be only sold with prescription]! And not only 
antibiotics but other medications should also be sold only with prescriptions. Doctors 
know the value, and patients know the value that without doctors they are nobody. And 
pharmacists think that they are doctors already. All medication should be sold only with 
doctors’ prescriptions. (ENT, age 34) 
P106: Actually, I think that most of the medications should be sold with medical 
prescriptions because now we have a total absence of authority [vsedosvolennost]. And 
such absence of authority leads to uncontrolled use of medications. (Gynaecologist, age 
60) 
Although enthusiastic about the re-articulation of their medical authority over pharmacists, 
the doctors explained that this change did not introduce major transformations to their daily 
routine. Rather, as no further changes in official standards of healthcare delivery were made, 
the amount of their work increased. The requirement for a standardised prescription meant that 





(about 15 min per patient):  
U106: Now, apart from medical recommendations that we print on computers, we have to 
write a prescription. But, we put our stamps and signatures on both of the documents. It 
takes more time. (GP, age 37) 
Discussing the meanings of the obligatory prescription, we asked the doctors about their 
diagnostic practices and about the kind of evidence that they used to decide about antibiotic 
treatment. By giving doctors the ultimate authority over diagnostic and treatment procedures, 
the prescription became a symbol of evidence-based decisions about antibiotic treatment. 
Similar to other studies in the field of antibiotic prescription practices, like the research of 
Broom et al. (2014) or Lambert et al. (2019), the doctors explained that they based their 
diagnoses on a combination of experience, personal clinical knowledge and institutionalised 
clinical recommendations. Apart from this, one of the ENTs explained that because a patient 
would only come to a specialist after a GP’s referral, this would be taken as evidence that a 
patient was eligible for antibiotics: 
L101: You know, patients will not immediately come to an ENT; they will always come 
from a GP or a paediatrician. They will get treatment at home for a common cold, and then 
they will come to us with complications. For example, there is no point in treating angina 
without antibiotics. The same is for sinusitis, it is impossible to treat without antibiotics. 
(ENT, age 34) 
Drawing on evidence-based decisions, a doctor could prescribe antibiotics to a patient. 
However, some of the doctors stressed that the notion of evidence included not only the clinical 
characteristics of patients but also their social and economic circumstances. As we noted 
before, apart from the introduction of a standardised medical prescription, no other changes 
occurred in the daily work of doctors. However, the requirement to go to a doctor for a 
prescription had stimulated an increase in the number of patients seeking a consultation. In 
addition, while a medical prescription aims to restrict practices of self-treatment it does not 
have the flexibility to incorporate potential reasons for this behaviour. Doctors who know the 
limitations of the healthcare system, including the limited amount of medical staff, and who 
are familiar with the economic restraints of patients who may be not able to take the time off 
work to visit a doctor have to compensate for these limits by adapting their antibiotic practices:  





U107: It happens sometimes that a child got ill on Friday. Saturday and Sunday are 
holidays, and the child has a high fever. I know that we should wait for 2–3 days [before 
prescribing antibiotics], but I don’t know whether they will call an ambulance or not on 
the weekend, so I can give them an antibiotic prescription and instruct how to use it in case 
the child feels worse. Either this way or if they don’t use the prescription now, they might 
use it next time if the child gets very ill. (Paediatrician, age 53) 
P102: I support this decision [change in antibiotic sale regulations]. However, patients will 
probably now have problems visiting doctors. Unfortunately, we cannot always provide 
quick care as patients, and also us doctors, often want. But still, taking the growing 
resistance to many antimicrobials, I think that most medications should be sold with 
prescriptions. (Urologist, age 45) 
The introduction of the obligatory medical prescription of antibiotics established medical 
doctors as an obligatory passage point to access these medicines to restrict practices of self-
treatment. It has also increased the workload and pressure on doctors as other elements of the 
healthcare delivery system have stayed intact: doctors have the same amount of time to receive 
a patient, and the number of medical staff have stayed the same. In our research we could see 
that, instead of restricting self-treatment with antibiotics, doctors might use their authority to 
prescribe medicines as a compensatory mechanism for the limits in the healthcare systems and 
for economic restraints of patients. The requirement for a medical prescription created informal 
networks of care delivery where evidence for an antibiotic prescription included the availability 
of medical staff and the opportunity for patients to visit a doctor.  
‘This system had started from the wrong end’ 
The requirement for a standardised medical prescription has restrained pharmacists’ 
authority to recommend and sell antibiotics. From a policy perspective, the introduction of this 
requirement into the healthcare system could be seen as a necessary step to establish a clear 
hierarchy where doctors give a prescription and pharmacists sell the antibiotics that are 
prescribed. In practice, however, pharmacists do something different. The obligatory 
prescription of antibiotics has allowed pharmacists to negotiate the practices and conditions of 
antibiotic prescription in a hospital. One of the pharmacists explained that prescriptions often 
missed a certain detail or were unclear, which meant that the pharmacist was put in a situation 
where he or she had to guess what medication was intended by the doctor. At the same time, 






F106: Very often doctors confuse forms [of medications]. For instance, cefixime can be in 
two different forms with different dosages, but they [doctors] only write ‘cefixime for 
seven days’. And you have to think and guess – should I give a regular one in capsules 
where there are six capsules in a box, or another one, where there are seven capsules. In 
the end, you sell regular capsules because they are cheaper, and people prefer to buy them. 
But actually, the doctor meant another form. This will result in a return of medication, and 
this is a conflict because nobody is praising us for returns [returns may cause financial 
conflicts between pharmacists and the administration of a pharmacy]. And actually, 
according to the law, we are not allowed to do returns. But it is 600 or 700 rubles [around 
10 euros], and it is essential for people. (Pharmacist, age 28) 
In addition, some pharmacists explained that doctors may not have used the standardised 
forms for prescriptions, but they are not allowed to sell antibiotics to patients with prescriptions 
on other forms: 
F104: I think that the situation with the requirement for a standardised medical prescription 
is good, and there should be some connection between a doctor and a pharmacist. But it is 
important to solve the problem with the standardised prescription forms because patients 
often comment that doctors don’t have those. (Pharmacist, age 32) 
This example indicates an interesting moment in the work of prescriptions. While they are 
intended to separate the responsibilities of doctors and pharmacists, instead they re-mediate 
their relationships, where pharmacists can observe certain pitfalls in the work of doctors, 
including the lack of necessary infrastructures like prescription forms. In addition,  pharmacists 
are positioned as mediators between doctors and patients; in the interviews they reflected on 
the working infrastructures of the new antibiotic policies through the stories of their clients:  
F101: [Q: for what reasons do people ask to sell them antibiotics without a prescription?] 
They don’t have time to go to a doctor, that is the first reason. There is a very long wait 
time to get an appointment with a doctor. For example, you cannot get to an ENT specialist 
because you need to have an appointment a month in advance. A child might have an acute 
exacerbation of sinusitis right now, but an appointment with an ENT specialist is only in 
a month. Also, it is impossible to go to a private doctor, for instance, because it is 





expensive. Actually, I think that this system [of control over the sale of antibiotics] started 
from the wrong end because it is necessary to first fix the system of appointments with 
doctors so that they [patients] can get a consultation the same day they need it. (Pharmacist, 
age 35) 
The requirement for a standardised medical prescription has influenced the communication 
between pharmacists and their clients. Several pharmacists described that since the introduction 
of the standardised prescription and the implementation of the control mechanism of surprise 
inspections they have been distinguishing between formal communication with new patients 
and informal communication with familiar patients. One pharmacist elaborated that familiar 
relationships with a customer may blur the line between the role of a doctor and the role of a 
pharmacist. In this situation, a pharmacist performed both diagnostics and selection of medical 
therapy:  
F103: To tell the truth, if it is our regular customer, maybe a child of a co-worker, then we 
can [sell antibiotics without a prescription]. So if there are no unfamiliar people in a line, 
if I am alone with a client, then I can do it [sell antibiotics without a prescription]. But if I 
see a person the first time, then of course not. (Pharmacist, age 20) 
Therefore, the requirement for a standardised prescription had stimulated the emergence of a 
grey zone, where antibiotics were manged between a pharmacist and a patient without the 
control of the state or the involvement of a doctor. This grey zone was justified by pharmacists 
as a necessary response to the current gaps in the infrastructure of healthcare delivery, including 
the lack of doctors in hospitals that made timely delivery of care problematic. It was presented 
as a form of care for patients whose social and economic situation might not allow them to take 
time off work to go to a doctor:  
F102: There are sometimes cases when we [pharmacists] recommend prescribed 
medications, but it is usually, for example, eye drops or something like that. Something 
for what a patient would not go to a doctor, but of course all antibiotics for eyes can only 
be sold with a prescription. But in these cases, we take responsibility because a person 
with conjunctivitis [eye infection] will not go to a doctor and will infect other people. 





The introduction of standardised medical prescriptions for antibiotics in practices of 
pharmacists has made visible the tensions between the work of doctors and the needs of 
patients. Although unable to officially recommend and sell antibiotics, through the use of 
prescriptions pharmacists can observe the infrastructural realities of doctors and highlight the 
gaps in these infrastructures, such as the lack of official prescription forms and lack of medical 
personnel to timely accommodate all patients. The standardised medical prescriptions 
coordinate the official channels of communication between a pharmacist and a patient, and 
they stimulate the creation of parallel grey zones. These grey zones can be understood as a 
response to AMR control programmes that aim to discipline patients’ behaviour without 
considering the social and economic context of these patients.  
‘Not everyone can take a day off work’ 
The presentation of patients as those exercising unhealthy behaviours of self-treatment 
with antibiotics is common in policy discourses on AMR (Haenssgen et al., 2018; Will, 2018). 
In this context, the requirement for a medical prescription often functions as a technique to 
prevent such unwanted behaviour. However, as studies of Rodrigues (2020) and Willis and 
Chandler (2019) show, self-treatment with antibiotics is not a question of choice but is 
influenced by social, economic and political processes, such as access and affordability of 
healthcare, non-therapeutic forms of care and the opportunity to take time from work to visit a 
doctor and convalesce. In our interviews with patients in Russia, we observed similar 
processes.  
Some of the patients saw the requirements for a prescription as a positive move that would 
protect people from the overuse of antibiotics. For instance, one of the patients told us that ‘the 
body of each person is different, and it means that you must do it [take antibiotics] only under 
a doctor’s supervision’ (P110, age 42). Other participants explained that it was difficult for 
them to accept the new requirements. Complexities regarding long wait times for clinical 
appointments, which was mentioned by both doctors and pharmacists, were further elaborated 
upon by patients. Having an appointment with a doctor would mean long wait times and the 
necessity of taking a day off work, which was a significant obstacle for some of the patients to 
access antibiotics:  
PT101: To tell the truth, when it all just started [stricter requirements for antibiotic 
prescriptions], I did not like it. I did not like that it was now necessary to go to a doctor 
every time. (Patient, age 31) 





PT102: Now I am ok about it [stricter requirements for antibiotic prescriptions], but when 
this requirement first took place [I did not like it]. Before you could just go and buy 
medications, because for some it was difficult to go for an appointment with a doctor; not 
everyone can take a day off work. (Patient, age 30) 
One patient was particularly critical about an antibiotic’s prescription requirements. She 
explained that instead of going to a doctor she preferred to rely on her pharmacist as it saved 
her time and money from potentially expensive antibiotic alternatives:  
PT107: It [amoxicillin] was once prescribed to me by a doctor. But it was a long time ago. 
Then I started to always buy it in a pharmacy; it is not expensive. And now it is very bad 
that I can buy it only with a prescription. It is really terrible for me! Because now you need 
to go to a doctor, pay money, and a doctor will prescribe you very expensive medications, 
very expensive – he will not prescribe a cheap one! And then I would have to run to a 
pharmacy. (Patient, age 49) 
In the Russian context, antibiotics can be understood as an economic tool, or as Pearson 
and Chandler (2019) call it, a ‘quick fix’. This tool is seen as something that can fix the body 
to make it productive again. While the requirement for a medical prescription aims to regulate 
the biological body of a patient and prevent self-treatment practices, the economic body of the 
patient perceives antibiotics as a requirement to stay productive in society, to earn money and 
to prevent poverty. Therefore, adapting to the new conditions which require a visit to a doctor 
as an obligatory passage point to access antibiotics, some of the patients explained that they 
would prefer to use leftover antibiotics rather than go to a doctor if their health conditions were 
not severe. Most of the patients from our study had leftover antibiotics at home from their 
previous prescriptions as in Russia you have to buy a whole package of medicine and not the 
exact amount that was prescribed by the doctor. A mother of a paediatric patient described a 
situation that was similar to the one described by one of the doctors – if a patient got ill on the 
weekend, she would not be able to receive specialised care on Saturday or Sunday. In this 
scenario, patients preferred to not wait until they would be able to see a doctor, but to start 
treatment with antibiotics if they had a chance:  
PT101: For example, it was a case that we had some leftover antibiotics. He [a child] 
recently had a tooth problem – he had gumboil. And it was a weekend and nobody could 





some friends who are clinicians and they recommended me to give him antibiotics to 
prevent any complications. And I had those leftover antibiotics, and I gave him one pill. 
Then, on Sunday, we came in an ambulance to a paediatric dental clinic. They told us there 
that we did good to give him an antibiotic. (Patient, age 31) 
Although self-treatment with antibiotics is presented in policy regulations, including the 
Global Action Plan on AMR, as a major problem in resistance development, several of our 
participants were very cautious about these medications (World Health Organization, 2015). 
Contrary to some studies arguing that patients demand antibiotics from doctors (Ashworth et 
al., 2016; Little et al., 2004), our participants expressed that they would prefer to avoid 
antibiotic treatment when possible as they thought of them as a strong medicine with serious 
side-effects. Those patients explicitly asked doctors to not prescribe them antibiotics and 
requested alternative treatment: 
PT102: If it is for kids, I ask whether it is possible to have treatment without antibiotics. 
Because I am worried. They probably have some side effects, such as milk fever or 
something like that. (Patient, age 30) 
PT103: [Q: Have you ever disputed a doctor’s prescriptions?] Yes, I asked for something 
else. I do not feel so bad as to need antibiotics. (Patient, age 67) 
Aiming to control the practices of self-medication, the requirement for a standardised 
medical prescription presents patients as potentially irresponsible users. However, our research 
shows that patients’ relationships with antibiotics reflects the broader social and economic 
realities of their life, rather than a simple lack of knowledge. Antibiotics were perceived as a 
necessity for their functioning in society, while at the same time many patients were cautious 
with them. Some of the reasons for avoiding official channels to access antibiotics were similar 
to the ones already articulated by doctors and pharmacists: while the introduction of the 
prescription required patients to coordinate their treatment practices with a doctor and a 
pharmacist, existing limits in healthcare delivery could not accommodate this requirement, 
leading to the creation of informal channels of coordination between those actors.  
Informal infrastructure to compensate for policy gaps  
In this article, we studied how the requirement for a medical prescription had affected 
practices of doctors, pharmacists and patients. The analysis showed that while this requirement 





aimed to establish a clear distribution of responsibilities between doctors and pharmacists to 
prevent patients’ self-treatment, in practice, it unpacked the infrastructural gaps that influenced 
self-treatment practices. The analysis showed that the requirement for medical prescriptions 
obliged patients to seek an appointment with doctors instead of going to the pharmacy to buy 
antibiotics. This, however, increased the pressure on the limited number of medical staff and 
stimulated the practice of just-in-case prescription of antibiotics by doctors. The system of 
over-the-counter sales of antibiotics did not disappear but became more clandestine and 
accessible only to friends and acquaintances. These informal practices involving doctors and 
pharmacists, which considered the socio-economic realities of patients, can be understood as 
compensating for infrastructural gaps, such as the limited number of doctors and corresponding 
insufficient availability of medical appointments, lack of official forms for prescriptions and 
the constrained economic situation of patients that does not allow them to take time off work 
to visit a doctor.  
The insights from our study confirmed the arguments of other scholars about the 
infrastructural embeddedness of antibiotic practices. Similar to the study of Broom et al. 
(2017), we could see that doctors, as well as pharmacists, adapted their antibiotic practices to 
the infrastructural conditions that might hinder patients’ access to timely medical 
appointments.  Also, along with the study by Willis and Chandler (2019), some of our patients 
understood antibiotics as quick fixes that enabled faster recovery and return to their social and 
economic responsibilities. However, our study demonstrated that antibiotic practices are not 
driven by economic factors exclusively. Rather, the organisation of healthcare delivery (e.g. 
the timetable for when the ambulance is working) and structural limits for access to certain 
specialists stimulated medical doctors to prescribe precautionary antibiotics in case a patient 
would not be able to access timely care. In addition, several of our patients-participants 
expressed that they would prefer a non-antibiotic treatment if they had a choice as they were 
worried about the potential side effects of these medicines. While the study of Little et al. 
(2004) demonstrated that doctors perceive pressure from patients to prescribe antibiotics, our 
findings showed that patients themselves would prefer alternative ways of treatment if that 
would help them to recover in their specific socio-economic reality. 
Analysing how AMR is constructed as a problem in public health, Chandler (2019) stresses 
that antibiotic practices are shaped by the infrastructural conditions in which they are situated, 
including physical organisation of care delivery (e.g. availability of diagnostic technology or 
number of medical staff) and social and economic demands to stay healthy and productive. 





infrastructure provides insights into the obligatory medical prescription of antibiotics as a 
boundary object of such infrastructure, which coordinates and aligns the work of the main 
actors. 
The concept of boundary objects was originally developed by Star and Griesemer (1989) 
in their analysis of the work of the Museum of Vertebrate Zoology at the University of 
California. They propose this concept to explain the processes of coordination between 
heterogeneous actors that were required to run this museum and to make exhibitions, such as 
amateur naturalists, professional scientists and philanthropists. They argue that the notion of 
boundary objects helps to understand how the complex work of diverse actors can be 
performed. An example of a boundary object is, for instance, a standardised system for disease 
classification (Bowker & Star, 2000). Such a system is simple enough that different actors, 
including medical doctors, technicians, nurses and insurance agents, can understand it; at the 
same time, the coding provides specific information for each of the actors: for a medical doctor 
a system of disease classification can indicate the line of treatment, and for an insurance agent 
it provides information about the applicability of an insurance policy to a concrete case. As 
such, this system aligns the work of both.  
In the context of new antibiotic policies to reduce AMR in Russia, the requirement for a 
standardised medical prescription can be seen as a boundary object facilitating the coordination 
between doctors, pharmacists and patients. However, some of this coordination work takes 
place outside of the officially established infrastructures to informally compensate for the gaps 
in care delivery. Imposed to coordinate new hierarchical relationships between patients, 
doctors and pharmacists, the obligatory medical prescription unpacks the current political 
economy in Russia. In this system, doctors and pharmacists have to informally accommodate 
the socio-economic conditions of patients who cannot afford to take time off work to be sick 
and sometimes live far away from healthcare facilities. This informally organised system of 
antibiotic care indicates that the officially established healthcare infrastructure does not reflect 
the economic and social realities of its patients. This coordination of obligatory antibiotic 
prescriptions escapes the hierarchy between medical doctors, pharmacists and patients when it 
comes to diagnosis and treatment. By navigating the antibiotic prescriptions, doctors, 
pharmacists and patients informally compensate for the gaps in this antibiotic infrastructure. 
While international and national policies continue to initiate behavioural interventions 
aimed at antibiotic users and prescribers, these users have to adopt practices to fix the gaps that 
become visible through these interventions. These frictions between the policy understanding 
of AMR and its everyday practical articulations indicate a gap between policy and practice. 





While the former imagines AMR as problem defined by the lack of knowledge among 
antibiotic users, the latter defines it as a consequence of economic and healthcare 
infrastructures that limit patients’ ability to be sick and take time off work. 
 In his study of pasteurisation in France, Latour (1988) argues that for an intervention to 
work, it has to be aligned with everything that allows it to work, in a process of mutual 
translation – the co-production of ideas and practices. In other words, to make AMR policies 
more efficient, the conditions that allow them to be efficient have to be adapted through the 
cooperation of local and national actors. As we saw in our research, the informal practices 
involving doctors, pharmacists and patients indicated the need for infrastructural changes like 
the increased availability of medical staff, increased time for a medical appointment and legal 
protections for patients as economic subjects that could fall ill and needed time for recovery. 
To reassemble the socio-economic and temporal infrastructures that influence antibiotic 
practices, it is important to take seriously the realities and practicalities that are communicated 
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In 2015, WHO issued a Global Action Plan emphasising One Health as an essential 
approach to tackle antimicrobial resistance (AMR). One Health aims to bridge human, animal, 
and environmental sectors to address shared health concerns (Craddock & Hinchliffe, 2015). 
One of the gaps in knowledge articulated by the Global Action Plan is scant understanding of 
social science and behaviour. In that context, One Health offers a potential for transdisciplinary 
collaborations, including between social and biomedical disciplines. WHO states that the role 
of social sciences in the One Health approach to AMR is dedicated to support effective 
antimicrobial stewardship programmes in human and animal health and agriculture. Although 
this role is essential for the success of AMR control programmes, it limits the potential of social 
science studies to support such programmes rather than to co-develop them based on both 
biomedical and social knowledge.  
Also in 2015, Smith wrote that AMR is a social problem; social science research has to be 
taken seriously in addressing the issue of AMR. Cultures of prescription, sale, and use of 
antibiotics in human and animal sectors, and practices of antibiotic production and waste 
management, are essential for understanding drivers of emergence and dissemination of 
multidrug- resistant bacteria (Broom et al., 2014; Chandler & Hutchinson, 2016; Kirchhelle, 
2018). Study findings substantiate the claim that AMR is not only a biological problem but 
also a social problem. Research by Collignon and colleagues shows that social and economic 
inequalities, poverty, and public health expenditures are major factors driving the global level 
of AMR (Collignon et al., 2018).  
If AMR can be considered a biosocial issue, solutions should neither lie exclusively within 
the biomedical disciplines nor fall into the social disciplines, but should reside on their 
intersections. In principle, the One Health approach offers an opportunity to develop a 
transdisciplinary and trans-sectoral agenda for AMR. However, findings of a study suggest that 
the One Health governing framework has an anthropocentric focus, positioning animal and 
agricultural sectors under the dominance of human health governing organisations 
(Kamenshchikova et al., 2019). Moreover, at the moment there are not enough conceptual, 
physical, and financial infrastructures to undertake transdisciplinary and trans- sectoral work. 
To create possibilities for transdisciplinary research, combining sociological and 
anthropological studies with microbiological research, funding needs to be organised; 
moreover, opportunities are needed to publish the results of transdisciplinary research, which 
combines very different types of data. It is important to think about concepts and approaches 





that go beyond One Health in capturing the multiple biosocial complexity of AMR, without 
prioritising one discipline over the other. Without a research infrastructure to build and sustain 
transdisciplinary collaborations, we are locked in disciplinary paradigms and will not 
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Alice: Would you tell me, please, which way I ought to go from here? 
The Cheshire Cat: That depends a good deal on where you want to get to. 
Alice: I don’t much care where. 
The Cheshire Cat: Then it doesn’t much matter which way you go. 
Alice: …so long as I get somewhere. 
The Cheshire Cat: Oh, you’re sure to do that, if only you walk long enough. 
 
Lewis Carroll, Alice in Wonderland 
 
Being a philosopher and entering the terrain of AMR, it has been fascinating to observe 
how this phenomenon is negotiated between different stakeholders. The WHO presents AMR 
as a global health concern that should be addressed on the national and international levels 
through increased surveillance, the development of new medications and control over the 
behaviour of antibiotic users (WHO, 2015). This perspective on AMR can also be found among 
biomedical and public health professionals (Pouwels et al., 2019). At the same time, social 
science scholars argue for a different perspective on AMR. While they also present it as a 
global health concern, they suggest that solutions should be found beyond the production of 
new medications and development of behavioural interventions (Hutchinson et al., 2018; Will, 
2018). In the field of social science, researchers argue that to address AMR as a global 
phenomenon, policymakers need to pay attention to the problem of access and distribution of 
current medicines, to the modern ways of production and trade and to the modern ways of 
understanding productivity and necessary time for convalescence. Observing these 
negotiations in the pages of scientific journals, I was inspired by the theoretical approaches of 
STS that allow for the analysis of facts as constructed (Latour & Woolgar, 1986; Mol, 2002). 
Instead of joining the debates on how to present AMR, I took a step aside and analysed how 
AMR is practised in different settings where various presentations of this phenomenon are 
constructed.  
This thesis is a report on my travels to different AMR settings and practices that have not 
yet been explored in the existing field of social studies on AMR. Without having a strict travel 
plan or detailed travel guide, I analysed the arenas of international policy, healthcare practices 
and scientific work. In this last chapter of the thesis, I will first summarise the main lessons of 
my travels. Next, I will reflect on the limitations of these travels and elaborate on how the 
characters in my travels enabled or hindered specific insights into understanding AMR. Then, 
I will explore the meaning of the results in relation to relevant theoretical discourses. 
 




Exploring diverse AMR settings  
I started my journey with an analysis of AMR practices in the international policy arena. 
This arena has been dominated by the One Health policy approach that aims to address AMR 
as a shared health concern between the human, animal and environmental sectors (European 
Commission, 2017; WHO, 2015). In chapter one, I explored how this approach influences 
AMR policies at the international level. In line with Asdal (2015), I theorised policy documents 
as an arena that does not simply describe AMR and One Health but constructs them as policy 
objects and influences practices of professionals working in the field of human, animal and 
environmental health.  
My analysis showed that One Health policy regulations, while aiming to unite the human, 
animal and environmental sectors, implicitly prioritise AMR as a human health issue, while 
animal and environmental health are presented as being potentially responsible for AMR risks 
that could influence humans. Reflecting on this analysis, I explored the potential of post-
humanism theories in understanding One Health because these theories suggest different non-
anthropocentric approaches to health. Rock (2017), in her critical analysis of the concept of 
public in public health and One Health promotion, argues that the health of different species 
should be understood as co-shaping each other because they all depend on and share the same 
environment. Hinchliffe and Ward (2014) propose the concept of folded life to understand 
human-animal-bacteria relations as making one another – they are folded together. The 
application of post-humanism theories to One Health policy regulations of AMR has 
highlighted how these regulations stimulate hierarchies between humans, animals, 
environments and between professionals who work in these sectors. I have concluded that the 
construction of such hierarchies can be rooted in the larger health policy arena from which One 
Health policy regulations of AMR are derived, which are primarily focused on human health. 
The analysis showed that it is quite difficult to develop symmetry between the health of 
different species and knowledge practices of different professionals. 
The next setting that I introduced in this thesis to study AMR practices was healthcare. I 
analysed two cases: AMR screening of refugees in the Netherlands and antibiotic control 
practices in Russian outpatient clinics. In chapter two I analysed how practices of AMR 
screening of refugees were perceived and constructed by different actors – Syrian refugees, 
microbiologists and public health professionals. This study was conducted in 2016 in a context 
of increasing policy attention to the incoming refugees in Europe, where this group had become 
an object of biomedical scrutiny for posing potential risks for disease dissemination (Maltezou 
et al., 2017). My analysis showed the diversity of perspectives on AMR screening of refugees. 




Microbiologists and public health doctors presented this screening as a potentially important 
public health measure, describing the importance of generating information about the overall 
AMR level in the community. At the same time, public health nurses dismissed AMR screening 
as potentially stigmatising for refugees, and they argued that screening had no clinical 
relevance. Refugees themselves perceived screening as permissible, but only if it benefited 
their personal health, not only public health. They stressed that if AMR screening is an 
important public health measure, it should be required from all travellers and not exclusively 
from refugees.  
I proposed to analyse the different perspectives on AMR screening of refugees through the 
concept of the tragedy of the commons; this concept refers to a situation where individual users 
of shared resources exercise practices that may be beneficial for them personally but harmful 
for the whole community that shares those resources. Applying this concept to AMR would 
mean that health is understood as a shared resource and AMR can be perceived either as a 
public health or individual health concern (Foster & Grundmann, 2006). In this context, AMR 
screening might be not justified if understood from the perspective of individual health because 
the screening of non-hospitalised people will not bring any benefits to these particular people. 
At the same time, if AMR screening is understood from a public health perspective, different 
individuals can be regarded as subjects of screening without considering potential individual 
harms to these individuals.  
I concluded that while AMR screening was often presented as a public health concern, 
screening practices that specifically focused on refugees separated this group from the public 
and presented them as being risky to this public. I suggested shifting the discussion from 
debates about the necessity of screening to the question of how this screening was organised. 
This meant the inclusion of refugees’ perspectives, as they were members of the public, and 
integration of their needs into the public health concerns for AMR. 
In chapter three I explored how AMR prevention was practised by medical doctors, 
patients and pharmacists in the context of Russian outpatient care. I analysed practices of 
healthcare professionals and patients in a context of changing policy regulations in Russia, 
where the over-the-counter sale of antibiotics has been strictly prohibited since 2017, when the 
requirement for obligatory medical prescriptions of antibiotics were introduced. In my 
research, I observed the adaptive practices that doctors, pharmacists and patients exercised in 
this new policy context. On the one hand, they argued that AMR was a serious problem and 
that antibiotics were important medications that should not be misused. On the other hand, their 
social and economic realities, including patients’ difficulties in taking sick leave and getting 




timely appointments with doctors, led to informal practices that allowed access to antibiotics 
without prescriptions.  
In my analysis, I engaged with social science literature, critically evaluating policies that 
defined AMR primarily as a behavioural problem of inappropriate prescription and use of 
antibiotics. Scholars like Chandler (2019) and Will (2018) argue that such policy approaches 
tend to overlook infrastructural conditions that determine antibiotic practices. These 
infrastructural conditions refer to the economic possibilities for patients to access non-
pharmaceutical forms of care and their ability to sufficiently convalesce, as well as non-
economic conditions, like personal relations between patients and doctors and between patients 
and pharmacists. Reflecting on this critique, in my analysis I concluded that while policies to 
control the over-the-counter sale of antibiotics in Russia were focused on the behaviour of 
antibiotic prescribers and users, the informal practices of these users compensated and adapted 
to the lack of infrastructural changes in the economic and social realities of healthcare providers 
and patients. These infrastructural realities included a lack of medical staff in hospital settings 
and the inability of this staff to deliver timely treatment within the officially established 
standards for care delivery. It also included the economic context of patients, including 
difficulties in taking the time off work to visit a doctor and thus staying ill.  
The last setting in my journey was the biomedical practices of AMR. Inspired by studies 
on metaphors in fields like synthetic and cell biology (McLeod & Nerlich, 2017; Reynolds, 
2018), in chapter four I presented the results of a discourse analysis of microbiological articles 
on AMR and travelling published between 2016 and 2018. In line with Reynolds (2018), who 
argues that metaphors in science should be understood as the ‘third lens’ of a microscope, I 
focused on metaphors in microbiology as tools that did not simply describe complex scientific 
phenomena but guided research processes and framed results. Language is not only descriptive 
but is also performative and political; that applies to scientific language as well as other types 
of language use (Asdal, 2015; Reynolds, 2018). I analysed how researchers described AMR 
and its transmission in travels between different parts of the world.  
I showed that microbiological articles described AMR transmission as a process in which 
‘ignorant’ and ‘unaware’ travellers ‘import’ bacterial ‘intruders’ from countries that are 
presented as ‘reservoirs’ of AMR to ‘high-income’ countries. Microbiological studies on AMR 
and travelling imagine a very specific notion of the world, where ‘healthy’ countries are 
separated from ‘unhealthy’. I have concluded that such presentations might overlook the 
potential imaginary of AMR as a networked phenomenon that highlights interdependencies 
between different places and practices of travelling. The separation of healthy and unhealthy 




countries implicitly reinforces the notion of national borders in a microbial global world where 
these borders offer limited protection when it comes to AMR. Therefore, the metaphors in 
microbiological research may threaten effective global policies to deal with AMR and 
travelling as a networked phenomenon that ties different places together. 
Calls for transdisciplinarity in AMR research have been predominant since the publication 
of the Global Action Plan in 2015 and the introduction of the One Health approach for 
addressing AMR. Following the Klein's (2017) definition of transdisciplinarity as a system of 
knowledge that ‘transcends the scope of disciplinary worldviews through an overarching 
synthesis’, in my thesis I worked in the transdisciplinary interface of the social sciences, 
humanities and biomedical sciences. In chapter five, where I presented the methodology of 
stool and stories, I explored the potential of transdisciplinary research combining methods of 
different disciplines. On a research team that included sociologists, microbiologists and public 
health specialists, we experimented with transdisciplinarity by putting two very different types 
of data – stool samples and stories – into a dialogue about AMR acquisition during international 
travel. This dialogue was organised around the data that we collected among a cohort of 
graduate students who travelled from different parts of the world to India for an education 
symposium. 
The result of this transdisciplinary dialogue shows that microbiology and social science 
speak very different languages when communicating about AMR. While microbiological data 
showed that students arriving in India had acquired a higher level of AMR than before their 
arrival, the sociological data demonstrated that students did not consider AMR to be relevant 
to their travel practices. In my analysis of the cooperation between microbiology and social 
science, I concluded that despite the aim to understand AMR as a biosocial phenomenon, 
biomedical and social science data existed in parallel to each other, but not yet connected as 
there was a lack of concepts, instruments, funding and infrastructural possibilities to co-
produce biosocial knowledge. Reflecting on this complicated dialogue, I argued that 
continuous practices of co-production of the biosocial methods and concepts for understanding 
AMR were crucial for bridging the laboratory and society. This bridging can open an 
alternative imaginary of infection preventions and surveillance, one that balances the social 
acceptance of such preventions and the biomedical approaches to it. Although it can be seen as 
speculative, transdisciplinary experimentation with microbiological and social science 
methods may result in democratisation of infection prevention, where social practices and 
understanding play equally important roles as the microbiological samples.  




In line with this, the last chapter of the thesis was a commentary about infrastructural gaps 
– namely in transdisciplinary concepts and methods, in accessibility of funding, and 
intransdisciplinary journals and platforms for knowledge co-creation – that may hinder the 
development of transdisciplinary work. This commentary can be considered a reflection on the 
whole journey of this thesis that I walked together with my supervisors from different 
disciplines. It indicated certain difficulties that we met in our research practices and highlighted 
the necessity of increasing funding and creating transdisciplinary platforms to stimulate the co-
production of knowledge about different aspects of AMR.  
The chapters of this thesis focused on very different settings and involved different actors, 
such as policy-makers, healthcare professionals, laypeople, microbiologists and scientific 
articles. In each of these settings, I described how resistant bacteria acted and were acted upon 
by society. In a sense, I showed how resistant bacteria became socialised differently depending 
on the setting and context where they were positioned. This diversity of social practices that 
surround and shape resistant bacteria highlights the necessity to approach AMR as multiple 
biosocial phenomena that cannot be addressed by universalistic and technical approaches that 
can often overlook the diverse social contexts where resistant bacteria are constructed.  
Travelling without a map 
I started this study as an Erasmus philosophy student working on a project about AMR 
screening of refugees, and I did not have a completed study design available I had to follow. 
The Erasmus project slowly developed into a PhD and studies of different settings were 
designed rather incrementally. Chapters of this thesis focused on different settings where I 
applied different methodologies and theoretical angles. A disadvantage of such an approach, 
this thesis does not present an in-depth analysis of AMR practices in one particular context, 
and it does not explore in-depth one specific theoretical approach. At the same time, the 
diversity of settings and practices that I explored allowed me to engage and highlight the 
differences showing that AMR was not a static, unified and standardised phenomenon, as often 
suggested in policy discourses (O’Neill, 2016; The Wellcome Trust, 2019). Rather, the 
diversity of case studies in this thesis points to the necessity for addressing AMR as multiple 
phenomena that are shaped by the biosocial worlds in which they are situated. The different 
theoretical perspectives that I applied in this thesis indicate various angles from which AMR 
can be approached. Therefore, the diversity of methods and theoretical concepts opened up an 
arena of diversity and experimentation where new biosocial approaches to AMR can be 
developed. 




During my travels through AMR worlds, I connected to different disciplinary backgrounds 
– my supervisors represented the disciplines of STS and social sciences, public health and 
microbiology – and I engaged with different disciplinary and theoretical approaches during the 
research. Throughout my PhD work, I learned some basic knowledge about microbiology and 
public health – about different types of bacteria and their behaviour, about different 
mechanisms of AMR and different laboratory tests and public health measures to control these 
bacteria. In STS it is important to stick to the symmetry principle: this means that beliefs (false 
or true) should be treated as equal and a researcher must remain impartial when explaining the 
causality of these beliefs. This also means that scientific phenomena are explained as 
intrinsically social and political. Learning about AMR as a member of a transdisciplinary team, 
rather than a sociologist observing biomedical practices, I was challenged to maintain this 
symmetry and to preserve a neutral position towards different types of knowledge. Studying 
practices of laypeople, doctors, pharmacists and policymakers, I was already ‘contaminated’, 
in the words of Zuiderent-Jerak and Bruun Jensen (2007), by certain perspectives from 
microbiology and biological understandings of AMR. This means that I was already embedded 
in knowledge practices and beliefs of microbiologists and public health professionals with 
whom I was working. This often made it challenging to impartially analyse AMR and antibiotic 
practices as neither good nor bad.  
Simultaneously, my philosophical perspectives influenced and contaminated the 
perceptions of my supervisors from microbiology and public health. One example is a 
conversation I had with my microbiology supervisor about the different types of knowledge of 
AMR. In one of the chapters in this thesis I wrote about a ‘perspective from the laboratory’, to 
which she argued that laboratories produce facts rather than perspectives. Interestingly, after 
this conversation, she commented that after several years working in such a transdisciplinary 
team, in which we critically analyse AMR knowledge production practices, she had started to 
question whether the laboratory actually produces facts, or perspectives that are argued to be 
facts. 
 Studying different AMR practices, I simultaneously participated in the transformation of 
these practices as a philosopher and as a member of the transdisciplinary team. Another 
memorable example of such co-contamination that we had in our team was a discussion about 
the potential title of this thesis as ‘Peace Treaty with Resistant Bacteria’. While the social 
science part of the team was quite intrigued by this idea, its biomedical counterpart argued that 
such an idea went against the aims of modern science and medicine to tackle these resistant 
bacteria. After an hour of discussion, we came to common ground with the idea of ‘Peace 




Treaty with Bacteria’ – a result of our co-contamination. We agreed that while modern 
medicine tries to tackle AMR, it does it through the practices of peace with other bacteria, like 
the development of probiotics or faecal microbiota transplantations.  
While it was challenging throughout my travels to stay impartial towards microbiological 
knowledge, to which I was constantly subjected, being part of a transdisciplinary team had 
important benefits. By working together, we subjected each other to different knowledge and 
practises, which allowed the co-production of hybrid knowledge that incorporated the diverse 
biosocial nature of AMR. Therefore, it opened up an important field for deeper research 
inquiries into the processes of socialisation by resistant bacteria. A combination of methods, 
metaphors and approaches created the opportunity for experiments, and I am convinced that 
we should continue with these experiments to overcome the separation between bacterial and 
human social worlds.  
Opportunity for theoretical experiments 
Although AMR has been studied by microbiologists since the discovery of the first 
antibiotics, it is a relatively new object of research in social sciences, and it has stimulated 
several theoretical developments. In different chapters of the thesis, I engaged with theories on 
post-humanism to describe human-bacteria relations, the concept of the tragedy of the 
commons to understand the ambivalent position of AMR in health practices and the concepts 
of infrastructures and informality to reflect on how health professionals and laypeople adapt to 
AMR policies. In addition, I explored practices enabled by scientific metaphors and theoretical 
approaches to transdisciplinarity. Although these approaches and the five chapters of this thesis 
analysed very different settings, they can be conceptualised in terms of the inversion of 
antibiotic infrastructures.  
The concept of antibiotic infrastructure has been elaborated by Chandler (2019) to explore 
the role of antibiotics in society. She builds on the work of Bowker and Star (2000), who 
introduced the concept of infrastructure in their analysis of classification systems. Bowker and 
Star (2000) argue that systems of classifications and standardisations are embedded and shape 
the social infrastructures that define our ways of living; thus, they define the ‘work practices, 
beliefs, narratives, and organizational routines’. The authors refer to the examples of 
infrastructure described by Becker (1982): the established standards for how music keys are 
written and how long a music concert should last define what kind of music can be written and 
what kind of concerts can be performed. Similarly, the established conventions about the 
dimensions of painting canvases (that it should fit onto a wall) pre-determine the type of 




paintings that can be drawn. These standards, rules, conventions and physical dimensions of 
musical instruments or art galleries are examples of infrastructures that are embedded into the 
daily routines and mundane understandings of what music should sound like and how big the 
paining should be. These infrastructures are invisibly interwoven into the conventions of living. 
 Bowker and Star (2000) develop this line of reasoning further and apply it to healthcare 
practices. Classification of patients as infectious and non-infectious define infrastructures of 
hospitals that have separate wards for different patients and different specialists working with 
these patients. These infrastructures are invisible and they guide the daily routines of a hospital. 
Classifications and standards that are shared between several groups, like standards for patient 
classification, are presented by the authors as boundary objects. These objects facilitate 
communication between heterogeneous actors, like doctors, nurses, insurance agents and 
patients, and allow them to work together while performing their individual tasks. For instance, 
while both doctors and insurance agents refer to the same system of patient classification, they 
use it differently – doctors develop treatment schemes, and insurance agents assess 
reimbursement plans. But it is these boundary objects that help different actors involved in the 
process of healthcare delivery coordinate their work practices. Boundary objects may include 
systems of patient classification, personal medical records, medical prescriptions or 
ultrasonograms that can be read by various professionals, who extract different information 
from it.  
The work of infrastructures can become visible, Bowker and Star (2000) elaborate, through 
the process of infrastructural inversion, which can be understood as a conceptual method to 
re-assemble the ‘depths of interdependence of technical networks and standards, on the one 
hand, and the real work of politics and knowledge production on the other’. Infrastructural 
inversion aims to unpack the nets of dependencies between different elements of infrastructure 
that make it work. Trying to diagnose a patient with signs of illness that have not yet been 
described and classified in medical protocols untangles the infrastructural organisation of how 
such classifications are produced and how they are embedded into the practices of healthcare 
delivery. Infrastructural inversion allows the challenge of existing, often invisible, 
conventions. The COVID-19 pandemic, which started at the beginning of 2020 and led to 
quarantine measures in different parts of the world, has challenged conventional ways of 
education delivery. In a way, this pandemic can be seen as an infrastructural inversion that 
unpacks conventional knowledge of communication practices (i.e. the length of a lecture, the 
maximum number of students in a class and the importance of laboratory work and practicums) 




and shows its dependencies from physical structures (lecture halls) and instruments (laboratory 
equipment) that currently define education processes. 
Building on this theoretical work, Chandler (2019) suggests analysing AMR as an 
inversion of antibiotic infrastructure. She aims to show that antibiotics are invisibly intertwined 
with modern understandings of healthcare and farming and more broadly with current political 
and economic processes that shape ideas of productivity and influence socio-economic 
inequities. Antibiotics influence modern understandings of hygiene and safety as non-bacterial 
and conventional healthcare practices of surgery and cancer treatment that would not be 
possible without antibiotics. Antibiotics are also embedded into the modern idea of 
productivity. In other words, the capacity of antibiotics to treat infections within a particular 
number of days defines how long a patient can stay ill before returning to work, which is 
translated into medical protocols and health insurance policies for covering a standardised 
treatment. Antibiotics also define the possibility of industrial farming by allowing a large 
number of animals in the same territory. Elaborating on these different examples, Chandler 
(2019) argues that antibiotics, as a biomedical phenomenon, should be understood as an 
infrastructure that shapes modern ways of living. Following this, she suggests conceptualising 
AMR as an inversion of such infrastructures as it allows questioning the modern social, 
political and economic processes that are shaped by antibiotics.  
Reflecting on the chapters in this thesis and engaging with the work of Bowker and Star 
(2000) and Chandler (2019), I would like to suggest a further analytical endeavour regarding 
the concept of infrastructure. Apart from understanding AMR as an inversion of antibiotic 
infrastructure because it shows our dependency on antibiotics in many ways, it can be fruitful 
to analyse bacteria, including resistant bacteria, as an infrastructure. Bowker and Star (2000) 
argue that ‘infrastructure does not grow de novo; it wrestles with the inertia of the installed 
base and inherits strengths and limitations from that base’. In addition, infrastructure is ‘never 
changed from above. Changes take time and negotiation, and adjustment with other aspects of 
the systems involved’ (Bowker & Star, 2000). Therefore, while resistance mechanisms of 
bacteria can be understood as an inversion of antibiotic infrastructure, bacteria themselves can 
also be analysed as infrastructure that establishes new connections and builds new boundary 
objects between new stakeholders who might have previously not been a part of the antibiotic 
infrastructure. In a sense, this conceptual alternative will shift the focus from antibiotic 
capacities to bacterial mechanisms and their manifestations. In the concluding section of this 
thesis, I would like to reflect upon this analytical experiment. 




Bacteria as a manifesting infrastructure 
Different chapters of this thesis showed how resistant bacteria have shaped new practices 
of various actors who had to adapt to new biological realities. Referring to the work of Bowker 
and Star (2000) it can be argued that bacteria turned into a material-objective force that creates 
and mediates actions and practices. In this context, bacteria can be understood as boundary 
objects. The concept of boundary objects was originally developed by Star and Griesemer 
(1989), who analysed how different actors with their diverse interests and goals can work in 
cooperation with each other. They studied how amateur naturalists, professional biologists and 
philanthropists built cooperations between each other that allowed the formation of the 
Museum of Vertebrate Zoology at the University of California from 1907–39. Star and 
Griesemer (1989) argue that the cooperation between different actors was possible because of 
two elements of translation between the work of these actors: the standardisation of methods 
and the development of boundary objects. The standardised methods allowed for 
communication between different actors involved in the process of knowledge production. The 
standardised way of labelling specimens connected the work of amateur collectors and the 
work of professional scientists; while the former collected specimens in nature, the latter could 
analyse them only if they were properly labelled according to the standards. However, 
standardised methods are not enough to ensure cooperation between different actors. Star and 
Griesemer (1989) elaborate that to cooperate, different actors create boundary objects that 
facilitate translation between their heterogeneous interests and values without diffusing them. 
A boundary object is an analytical concept that refers to ‘objects which both inhabit several 
intersecting social worlds and satisfy the informational requirements of each of them’. A library 
can be understood as a boundary object: diverse actors can use a library as a source of 
information or as a workspace, though they do not necessarily have to negotiate these 
differences between each other.  
Following this line of argument, bacteria, both resistant and non-resistant, can be analysed 
in terms of infrastructure. This means analysing how bacteria and their mechanisms are 
interwoven into the conventional infrastructures related to health and illness. For instance, we 
clean our hands with soap to keep bacteria out and to stay healthy; we also eat yoghurt and take 
probiotics to have bacteria inside our bodies and to stay healthy. By defining health and illness, 
bacteria influence the conventions of interpersonal relations and the notion of social living with 
bacterial others. They also shape economic and policy processes, disturbing or opening up 
opportunities for international trade and mobility.   




Being part of different worlds and work practices, bacteria enable multiple processes of 
cooperation between heterogeneous actors, like healthcare professionals and farmers, or 
refugees and microbiologists. These processes involve both the creation of boundary objects 
to allow for cooperation between these actors and – simultaneously – the creation of boundaries 
between them. While bacteria connect the health of humans, animals and the environment, they 
simultaneously create infrastructural, hierarchical boundaries between these sectors and 
between different species. Similarly, in scientific research, bacteria can be seen as connecting 
the different geographical territories highlighting their routes of transmission. But this can also 
stimulate the creation of boundaries between those territories as ‘healthy’ or ‘unhealthy’. 
To conceptualise the work of bacteria as infrastructure, it is important to recognise that 
infrastructure is never neutral. Bowker and Star (2000) elaborate on the political nature of any 
infrastructure that brings forward certain perspectives while silencing others. They give an 
example of how school systems classify students based on their standardised test results that 
valorise only certain knowledge skills while making other skills invisible; for instance, a test 
may show that a student can calculate a certain mathematical formula, but it does not show that 
a student can also critically reflect on this formula as faulty. Another example from their work 
is the infrastructure of the US Immigration and Nationalisation Service. This service classified 
particular social classes and people in terms of skills, and in the classification system specific 
skills like computer engineering were considered desirable. The use of this classification 
resulted in a quota system where people from more affluent countries were preferred over 
people from poorer countries.  
In line with this, Law and Mol (2008) argue that material artefacts and processes can be 
understood as political. Analysing practices of boiling pigswill in UK farms, they show that a 
material object or material practices can be analysed as performing political work. Elaborating 
on the technique of boiling pigswill, the authors explain that this technique aims to protect pigs 
from bacteria, which could be present in illegally imported meat from countries where foot and 
mouth disease is endemic. However, not all farmers follow it, which means that infected 
illegally imported meat can reach pigs. Thus, Law and Mol (2008) show, boiling pigswill can 
be seen as a political technique that implicitly divides the world into ‘disease-free countries’, 
like the UK, and ‘countries where foot and mouth are endemic’, like Bangladesh. 
Considering infrastructure as political, it is important to reflect upon the politics of 
bacteria. Analysing bacteria as an infrastructure that performs material politics allows for 
scrutiny of what kind of hierarchies are developing, what perspectives are dominant and which 
are silenced. Therefore, an infrastructure of bacteria stimulates a further analytical endeavour 




towards new social, economic and political relations moving beyond antibiotic-related 
practices.  This means that we shift the focus from antibiotics to bacteria, analysing how these 
microorganisms influence and shape our societies: what the role of bacteria is in the 
organisation of healthcare practices, the practices of inter-personal relations and practices of 
animal husbandry; how bacteria move across national borders and what conditions they 
establish for trade and human mobilities and how the prevalence of bacteria in different areas 
of the world shape international relations and immigration law between these areas – to answer 
these questions we need to untangle bacterial infrastructures. 
Becoming a part of the One Health policy arena, resistance bacteria have stimulated new 
practices and standards for professionals working in healthcare, animal husbandry and 
agriculture. As any emerging infrastructure, bacteria have connected to the already established 
basis of international health regulations that focus on human health control and prevention and, 
in line with that, bacteria have stimulated a policy trajectory to protect the health of humans. 
In the already existing context of One Health, the bacterial infrastructure brings forward the 
interests of some actors while backgrounding others. Certain sectors, like wildlife, have 
become predominantly silenced in the political arena of infection management. Different 
knowledge practices have also been arranged in an unequal way where biomedical knowledge 
about human health has prevailed over social science insights. Reflecting on One Health as a 
boundary object within bacterial infrastructure unpacks the emerging processes of cooperation 
between different sectors and assignation of different values and responsibilities to each of 
them.  
We can observe similar processes in public health and clinical settings. The potential threat 
of resistant bacteria that became associated with some mobile groups, in particular with 
refugees, has stimulated the development of screening practices. These screening practices can 
be analysed as both consequences of public health control and as a cause of potential 
stigmatisation of refugees as dangerous others. Engaging with practices of refugees, 
microbiologists, public health doctors and public health nurses, I showed how these groups 
were engaging with resistant bacteria. AMR screening, while being contested by some actors 
and supported by others, navigates the relationships and practices between these heterogeneous 
actors. Although it was debated upon by different participants in my research, the technique of 
screening applied to refugees has already brought forward the health risk voices of the 
biomedical community and silenced those from public health nurses and refugees.  
In clinical settings, the problematisation of AMR as self-treatment with antibiotics has 
stimulated policy developments to control the prescription and use of these medicines. The 




analysis of emerging control policies, particularly obligatory medical prescriptions, as 
boundary objects that navigate the collaboration between doctors, patients and pharmacists 
opens up an interesting perspective on this collaboration. My analysis showed that obligatory 
medical prescription has stimulated informal collaborations amongst doctors, patients and 
pharmacists to deliver care beyond governmental restrictions. In a way, Bowker and Star 
(2000) highlight that infrastructure is ‘never changed from above’ and that ‘changes take time 
and negotiation, and adjustment with other aspects of the systems involved’. These adjustments 
can be seen in the case of Russian healthcare practices that utilise informal communication to 
adapt to the new realities manifested by resistance bacteria. 
In the scientific arena of AMR research, heterogeneous actors, including researchers, 
medical professionals, funders, policymakers and laypeople, contribute to the process of 
knowledge production. Research technology, methodology and protocols and scientific 
language and its metaphors can be considered boundary objects that influence the processes 
and the results of knowledge production. An emerging concern for resistant bacteria has been 
reflected in the developments of new diagnostics, new microbiological lab equipment and new 
metaphors that describe the ‘import’ of bacterial ‘intruders’ from countries with ‘low level of 
hygiene’ to ‘high-income countries’. The presence of resistant bacteria enables hierarchical 
imaginings of a world that has become divided into ‘healthy’ and ‘unhealthy’. 
Expanding the focus from antibiotic infrastructure to bacteria as infrastructure provides 
insights into how these bacteria have established different social worlds. Studying the history 
of antibiotic development and the use of these medications, Landecker (2015) shows how this 
history has manifested itself in the biology of bacteria that acquire resistant mechanisms. She 
shows how human history and modern ways of living have been built on the opportunities that 
were opened up by antibiotics. Many studies in social science have demonstrated the 
functioning of the antibiotic world: the concept of illness as something technical that can be 
quickly tackled, the concept of hygiene as something sterile and non-bacterial and the various 
practices of mobility as something safe and non-risky (Hinchliffe & Ward, 2014; Newman et 
al., 2016; Willis & Chandler, 2019). However, these studies also show that the antibiotic world 
is slowly losing the war against bacteria. Therefore, the shift, both analytical and political, from 
antibiotics to bacteria enables the imagining of a different type of social living and the 
adjustments that are necessary for this living. Focusing on the mechanisms and capacities of 
bacteria rather than the opportunities of antibiotics allows the exploration of potential peace 
with bacteria that make our living possible. 




When my supervisors and I were debating the idea of a peace treaty with bacteria, we 
concluded that many current practices of dealing with infectious diseases could already be 
understood as steps towards this peace (e.g. a delay in antibiotic treatment or the development 
of probiotics or faecal microbiota transplant). Reflecting on my journey through the different 
settings and practices related to AMR, I came to the realisation that being a part of a 
transdisciplinary research team was one of the most important elements of this journey. 
Discussing various social practices that I was analysing in my fieldwork, I was in a continuous 
dialogue about the role and mechanisms of bacteria in these practices. This focus on bacteria 
was something I found to be limited in many policies and social science debates about AMR. 
Understandably, social scientists would not debate about the biology of bacteria but I think we, 
as a research community, need to take important steps towards the integration of bacteria into 
the social world and vice versa. The socialisation of bacteria, not only antibiotics, is a crucial 
step in understanding how to make the micro and macro worlds coexist. 
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Societal relevance is an important component of scientific research, and Maastricht 
University encourages explicit reflection upon this aspect in a separate chapter of a PhD thesis. 
Therefore, here I will outline how my journey through different AMR practices has contributed 
and will contribute to the development of practical and analytical tools for understanding and 
communicating this phenomenon. I will reflect upon new opportunities for research and 
policymaking that can be opened up by transdisciplinary collaborations, and I will describe 
how the results of this thesis have been disseminated among health professionals and laypeople. 
New opportunities for transdisciplinary understanding of AMR 
In the arena of health policy, AMR has often been understood as a biological fact, the 
solution for which can be found in laboratories that produce new technologies for AMR 
screening and new medications for the treatment of infections (O’Neill, 2016; WHO, 2015). In 
this context, human practices of antibiotic use have been problematised as something that needs 
to be fixed through awareness campaigns and behavioural control programmes (Rodrigues, 
2020; Will, 2019). We can see such conceptualisations of AMR in the Global Action Plan on 
AMR by the WHO, OIE and FAO (2015), in the European One Health Action Plan against 
AMR (2017), and in the influential report on AMR by the British economist Jim O’Neill (2016). 
However, as I have shown throughout this thesis, such approaches to AMR have been widely 
criticised by scholars in the biomedical and social sciences (Chandler, 2019; Larsson, 2014; 
Will, 2018). One of the major points of this criticism is that AMR is not only a biological but 
also a social phenomenon, which is shaped through various social, economic and political 
processes (Chandler, 2019). In addition, neither the biological nor the social nature of AMR 
can be understood as a fixed fact because knowledge about bacteria and their social 
embeddedness is constantly changing. Therefore, scholars in both the biomedical and social 
sciences have argued for more nuanced approaches to AMR that reflect the social context and 
the biological uncertainties of this phenomenon (Chandler et al., 2016; Collignon et al., 2018; 
Smith, 2015).  
Following the traditions of STS that suggest analysing knowledge as constructed through 
different practices (Latour & Woolgar, 1986), this thesis unpacked several systemic and 
infrastructural nuances that have influenced AMR practices and shaped AMR in different 
settings. This approach did not dismiss the biological nature of AMR, but it engaged with 
bacteria as a social phenomenon that influences and is influenced by policymaking practices, 





constructed, this thesis also tried to bring together biological and social constructions of 
bacteria.  
The analysis of the social life of AMR opens up opportunities for alternative research and 
policymaking, where AMR is conceptualised as a biosocial phenomenon that can be addressed 
through transdisciplinary collaborations. Transdisciplinarity is often understood as an 
ambitious project for systemic integration of knowledge that ‘transcends the scope of 
disciplinary worldviews’ (Klein, 2017). This integration allows the development of more 
comprehensive, holistic understandings formed by a diversity of languages, methods and 
epistemic practices (Hackett et al., 2017). The importance of transdisciplinarity in AMR 
research and policymaking is emphasised by the urgent need for transformation of the current 
practices, policies and economic organisations that are not able to respond to the growing 
concern about AMR. AMR is a complex issue, and different specialist approaches are not able 
to resolve it on their own. Transdisciplinary approaches and the integration of biosocial 
perspectives to address the biosocial phenomenon of AMR are crucial steps that require the 
transformation of research infrastructures and policy choices that present AMR as static and 
universal in every social context.  
Studies in microbiology have shown that AMR refers to various microorganisms and 
various mechanisms of resistance, which can be natural or acquired (Cox & Wright, 2013; 
Reygaert, 2008). Studies in social sciences have demonstrated how various social and political 
processes shape different antibiotic practices, including antibiotic use, distribution and waste 
management (Collignon et al., 2018; Lambert et al., 2019; Willis & Chandler, 2019). However, 
the insights from these two very different disciplines have rarely been put into a dialogue with 
each other, which hinders the production of adequate explanations of AMR (Smith, 2015). The 
lack of such dialogue can be seen in policy approaches to AMR that neither fully engage with 
the biology of bacteria nor with its diverse social practices. Namely, environmental aspects of 
AMR are largely outside the political scope as are economic and social inequalities that hinder 
access to antibiotics. Instead, national awareness campaigns, as well as international policy 
regulations, narrow their approaches to AMR as something technical that can be solved by the 
production of new antibiotics and changes in antibiotic use by implementing guidelines and 
protocols (Hinchliffe & Ward, 2014; O’Neill, 2016; Will, 2019). 
Engaging with the biosocial diversity of AMR, rather than focusing on its selective 
features, is a necessary shift for the development of comprehensive and meaningful approaches 
to resistant bacteria. To allow this shift, biomedical and social sciences should be engaged in a 





knowledge production, including the use of scientific language, methods and theoretical 
instruments. This questioning of epistemic practices will provide a basis for ‘co-contamination’ 
of these practices – introducing the insights of the social science world into the world of the 
laboratory and vice versa. Although the concept of co-contamination may go against the 
methods of different disciplines that have their established vocabulary and conventions of 
dealing with research topics, it opens the window for innovation and alternative approaches 
that may be impossible within the frames of one discipline.  
The current disciplinary separation of biological and social studies of AMR hinders the 
potential integration of knowledge produced in these disciplines. By studying the biology of 
bacteria, microbiologists also learn about the biological dynamics of social worlds from where 
these bacteria came from and what practices they were a part of. In a similar way, by studying 
social practices and the processes related to health and hygiene, social scientists learn how 
bacteria become part of social, political and economic processes. The biological and the social 
nature of AMR is manifested in the bacteria themselves; however, the epistemic practices that 
produce knowledge about the biosocial nature of bacteria are currently separated. 
To open up the opportunity for transdisciplinary research between the biological and social 
aspects of AMR, we need to revisit the epistemic distinction of knowledge production 
practices. The work of the STS scholar Latour (1983) may serve as a helpful guide here. 
Reflecting on the transformative capacity of a laboratory, Latour (1983) rephrased the famous 
Archimedean expression into the following: ‘Give me a laboratory and I will raise the world’. 
By rephrasing a famous Greek motto, he aimed to address a crucial distinction between the 
micro and macro level of social studies of science, where the former refers to the analysis of 
the interpersonal relationships between people or social groups, and the latter refers to the 
analysis of social institutions. To show the meaninglessness of this distinction, Latour (1983) 
refers to his analysis of the laboratory work of Louis Pasteur and his development of the anthrax 
vaccine.  
Following the work of Pasteur, Latour shows that the introduction of the vaccine was not 
a clear and linear process from the laboratory to society. Rather, Latour (1983) argues, Pasteur 
first had to convince farmers, veterinarians and hygienists that anthrax was caused by bacteria 
– he had to make this bacteria visible for others in his laboratory. He then had to convince them 
that there was a cure that could tackle this bacteria – he did experiments in his laboratory 
showing the vaccine worked. Then he had to convince them once more that the vaccine worked 
not only in his laboratory but also on farms, if farmers followed his instructions. Given this 





that would usually be referred to as micro-level – a researcher can see the social (or macro) 
transformations of society. Latour shows how, by convincing different actors in society (e.g. 
veterinarians, farmers and hygienists), Pasteur introduced the Bacillus anthracis as a new actor 
in this society, which he could control. But to establish this control, Pasteur did not just release 
the vaccine to society for free use, he turned society into his laboratory by setting the conditions 
under which this vaccine would work. That’s the motivation for the Latour’s alteration of the 
Archimedean motto – for Pasteur to introduce an anthrax vaccine, he had to turn the world into 
his laboratory and make the Bacillus anthracis a part of this world. 
The reason I introduced the work of Latour (1983) here is to highlight once again that the 
laboratory and society do not exist in two parallel worlds, where the scientific facts from a 
laboratory are simply transferred to society. Rather, these two worlds co-create each other. A 
laboratory can raise the world by turning it into a laboratory and introducing new inhabitants 
to it. But the world can be turned differently, depending on what laboratory it is. Pasteur turned 
the world into a microbiological laboratory, introducing microorganisms with their biological 
mechanisms as the new inhabitants. These biological microorganisms, according to Pasteur, 
could be conquered with his vaccine. However, the laboratory world that Pasteur introduced 
did not incorporate the socio-economic divisions and inequalities that can be shaped by these 
microorganisms via access to vaccines. Establishing transdisciplinary laboratories and 
allowing the co-contamination of biological and social sciences may result in the creation of a 
different world where micro-organisms and their biological mechanisms have to co-exist with 
macro-organisms and their social practices. This is a necessary step for understanding bacteria 
and their socialisation processes.  
Communicating antimicrobial resistance  
Throughout my research, I organised several events to communicate my findings on AMR 
to professionals and laypeople. One of these events was Antibiotic Awareness Day, which took 
place at the Siberian State Medical University on 21 March 2018. Organising this event, I 
invited professionals from three different disciplines: medicine, microbiology and philosophy. 
Such disciplinary diversity enabled discussion of AMR as a biosocial phenomenon, 





medical university, which attracted many 
medical students who often did not work with 
non-biomedical dimensions of AMR. In total, 
about 50 people participated in the event.  
Following Antibiotic Awareness Day, in 
collaboration with a medical doctor from the 
Siberian State Medical University, I 
organised two social science student research 
projects on AMR. Both projects aimed to 
understand antibiotic practices of patients and 
medical doctors in Tomsk, Russia. 
Throughout these projects, I provided 
students with several workshops on 
qualitative methods and transdisciplinary 
approaches to AMR. The major aim of these 
projects was to introduce students to the 
importance of knowledge diversity in 
understanding and addressing such phenomena as AMR.  
Apart from education projects in Russia, I developed a case study on AMR for one of the 
learning activities within the Philosophy in Action course at Maastricht University. This course 
was taught in the health sciences bachelor’s programme, and it invited students to reflect on 
different biomedical topics by applying the theories of ethics. In addition, I developed two case 
studies for the course Communicable and Non-communicable Disease in the EU and WHO 
European Region for the European public health bachelor’s programme at Maastricht 
University. These case studies aimed to show students the importance of transdisciplinary 
communication and collaboration in addressing such phenomena as AMR. Bringing together 
the insights from both biological and social sciences, I showed students the various angles that 
different knowledge practices can bring into their future professional practice.  
The insights from my research have also been communicated to different professionals in 
the field of microbiology. I was invited to participate in the research day of the Microbiology 
Department of Maastricht University where I presented the results of the project that was 
described in Chapter 2. This engagement stimulated some important conversations on how we 
can bridge different types of knowledge that have been produced in various disciplines.  
Poster from the Antibiotic Awareness Day 
at Siberian State Medical University on 





Assembling a biosocial puzzle of knowledge practices  
Within the last decade transdisciplinarity has increasingly become an important 
component of much research and one of the requirements for funding (Hessels et al., 2010; 
Mattsson, 2015). Transdisciplinarity was also at the core of my research in that I collaborated 
with microbiologists and public health professionals. Many studies that aim to combine 
different types of knowledge run the risk of co-existing on the same project without co-
producing results (Parker, 2010). To address this risk, one of the aims of my research was to 
build a coherent collaboration with professionals working with the biological side of AMR. 
The methodology of stool and stories that was presented in chapter five is a result of this 
collaboration where I aimed to bring microbiological and social science knowledge into a 
dialogue with each other.  
To stimulate the development of 
transdisciplinary knowledge 
production practices, I co-organised a 
symposium on the cross-border 
movements of microorganisms. The 
symposium took place in Maastricht 
on 22 November 2018, and it brought 
together professionals from 
anthropology, microbiology, art, 
infectious diseases and sociology. As 
a result of this symposium, together 
with six other participants, I applied 
and received the Mingler scholarship to conduct a collaborative research project that will 
combine insights from microbiology, epidemiology, sociology and art. Following the insights 
from my thesis work, this research project will develop an understanding of the cross-border 




Picture from a transdisciplinary symposium on the 
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Introduction. Antimicrobial resistance (AMR) is a growing public health concern 
globally that calls for comprehensive transdisciplinary approaches. Although AMR refers to 
biological mechanisms of bacterial resistance, it is a deeply social phenomenon that is 
influenced by economic, political and cultural processes. Studies in microbiology have 
provided important insights into the biology of bacteria and their different ways of acquiring 
resistance. In turn, studies in social sciences have shown how antibiotic-related practices, 
including prescription, use, production as well as utilisation of antibiotic waste may influence 
the development of AMR. In this thesis, I took a step forward from studying antibiotic-related 
practices and analysed how AMR is incorporated and practised in different settings of policy, 
healthcare and science, and what kind of reality is constructed through these practices.  
This thesis is a report of my journey through settings where I studied how AMR has been 
changing the social worlds of different actors. These settings included the world of 
international policy regulations on AMR and One Health approach to it; the world of public 
health AMR screening of refugees in the Netherlands; the world of antibiotic practices among 
medical doctors, pharmacists and patients in Russia; and the world of science with its diverse 
metaphors and methods to address AMR. The different chapters of this thesis elaborate on my 
findings from the journeys to each of the social worlds and their practices.  
Chapter 1 analyses the policy world of AMR where the One Health approach has been 
gaining popularity since the publication of the Global Action Plan on AMR in 2015. Analysing 
international policy regulations on AMR, as well as more general health regulations from 
which AMR documents are derived, this chapter reflects on how the One Health approach 
shapes AMR in the international policy arena. Policy documents are understood here as 
performative – they are not simply describing the reality about AMR and One Health approach 
to it, but they construct this reality and influence practices of individuals involved in the human, 
animal and environmental sectors. The chapter engages with the theories of post-humanism to 
critically examine the modes of relations between the human, animal and environmental sectors 
that One Health approach to AMR proposes. It shows that despite the One Health ideal to build 
inter-sectorial collaborations for addressing shared health concerns, AMR policy regulations 
that implement One Health shape hierarchies between the health of different species and 
between knowledge practices of professionals working with these species.  
Chapter 2 shifts the focus from the policy arena to public health practices of AMR 





as a potential risk posed by the incoming refugees. Focusing on different perspectives of 
microbiologists, public health doctors, public health nurses and refugees, AMR screening is 
shown to be a constructed phenomenon that can be understood as either a necessary public 
health measure, an unnecessary stigmatising technique, or a potential for the improvement of 
personal health. While the debates about the necessity of AMR screening of refugees have been 
taken place on the pages of scientific journals, this chapter reflects on a different question: how 
to perform an AMR screening of refugees to accommodate the diverse perspectives of different 
actors? The chapter is arguing for the need for co-production processes in developing and 
implementing the technique of screening, where the public health needs and potential risks of 
stigmatisations are equally considered.  
Chapter 3 moves from the world of public health in the Netherlands to the world of 
healthcare practices in Russia. This chapter analyses antibiotic practices of medical doctors, 
pharmacists and patients against the background of the recently introduced policy requirement 
for the medical prescription on antibiotics. While this requirement aims to tackle the over-the-
counter sale of antibiotics defining AMR as a problem of self-treatment, the chapter provides 
a more nuanced reflection on how AMR is practised and how antibiotic care is organised in 
Russia. Self-treatment practices with antibiotics are the results of different processes, including 
the lack of medical personal in the clinical settings that hiders a timely provision of care, and 
the inability of many patients to take time off work to visit a medical doctor. Recognising these 
different processes, medical doctors, pharmacists and patients adopt informal techniques to 
deliver and access antibiotics beyond the policy requirement for medical prescription. The 
chapter analyses these informal techniques as compensatory responses of healthcare 
professionals to the gaps in the official healthcare system.  
Chapter 4 focuses on how microbiologists imagine AMR as a global phenomenon, which 
can be transmitted and disseminated from one country to another. Analysing metaphors that 
microbiologists use in their scientific articles on AMR and travelling, this chapter shows how 
the notion of global is presented in a very specific way. Using such metaphors as AMR 
‘reservoirs’ and bacterial ‘intruders’, the metaphors in microbiology imagine the global 
transmission of AMR as a linear process where bacteria from low-income countries are 
transmitted to high-income countries with ‘better hygiene’. The chapter argues that metaphors 
are not just figures of speech, but they help in navigating scientific research processes. 
Describing certain countries as AMR reservoirs and other countries as those with better 
hygiene may lead to the one-sided research processes, where the potential transmission of 





Chapter 5 describes an experimental methodology ‘stool and stories’ that was developed 
by Maastricht University team to study AMR as a biosocial phenomenon. Following the cohort 
of graduate students who travelled from different parts of the world to India, this chapter brings 
together the data from microbiological stool sample analysis and the data from semi-structured 
interviews conducted with the same cohort. The two diverse sets of data focus on the same 
research question about the importance of AMR for international travelling but give different 
answers to this question. While microbiology highlights the potential risks for acquiring AMR 
when travelling internationally, social science data shows that travellers themselves do not 
consider AMR to be a relevant health problem in the context of travelling. This difference in 
answers demonstrates the important gap between the biological and social constructions of 
AMR, which are currently not connected. 
Chapter 6 is a short reflection on my PhD journey as a transdisciplinary practice. This 
reflection argues for the infrastructural changes in the current ways of organising knowledge 
production practices that separate biomedical and social science approaches to AMR. Rather, 
the collaborative platforms, including academic journal and conferences, and transdisciplinary 
funding for understanding AMR should be established and promoted at the national and 
international levels.  
General discussion and conclusion. The six chapters of this thesis focus on different 
settings and various practices of AMR. This diversity highlights that AMR is not a static and 
universal phenomenon that can be addressed in a similar way regardless of the context. On the 
contrary, the different insights from each of the chapters show that AMR acts and is acted upon 
in various ways depending on the hierarchies between different species and disciplines, the 
perceptions of risks, the available opportunities for treatment, and the language and methods 
of scientists who analyse and address AMR. 
Departing from the analysis of antibiotic practices and focusing on how AMR is practised 
in different settings, this thesis offers an alternative analytical and political shift in 
understanding this phenomenon. It is a shift from antibiotics as a leading focus for 
understanding social and political processes related to AMR, to bacteria and changes that they 
introduce to social where they are situated. This shift allows for the understanding of AMR 
beyond antibiotic-related practices, AMR is analysed as constructed through the language of 
scientists and as a part of the daily reality of travelling and human mobilities. This has also 
political implications as it requires a change in the paradigm where social worlds with their 
daily practices of travelling, healthcare and farming have to be adapted to the biological 






Inleiding. Antimicrobiële resistentie (AMR) is wereldwijd een groeiend probleem voor 
de volksgezondheid dat vraagt om een transdisciplinaire benadering. Microbiologische studies 
hebben belangrijke inzichten geleverd in de verschillende manieren waarop bacteriën 
resistentie verwerven. Onderzoek in de sociale wetenschappen heeft op haar beurt aangetoond 
hoe sociale-, politieke- en economische processen antibiotica productie, gebruik, en afval 
beïnvloeden en daardoor de ontwikkeling van AMR bevorderen dan wel remmen. Tegen de 
achtergrond van dit onderzoek heb ik geanalyseerd hoe AMR wordt geconstrueerd in 
verschillende settingen – beleid, gezondheidszorg en wetenschap. Het proefschrift is als het 
ware een verslag van mijn reis door deze verschillende werelden van AMR. Ik bestudeerde de 
ontwikkeling van de One Health-aanpak in de internationale beleidsarena; perspectieven op 
AMR-screening van vluchtelingen in Nederland in het kader van de volksgezondheid; omgang 
met antibiotica-richtlijnen door artsen, apothekers en patiënten in Rusland; en het gebruik van 
metaforen in microbiologisch onderzoek naar de relatie tussen AMR en internationaal 
reisgedrag. De verschillende hoofdstukken van dit proefschrift zijn een verslag van mijn reis 
naar een van deze werelden.   
Hoofdstuk 1 analyseert de beleidsarena waarin de One Health-aanpak, die sinds de 
publicatie van het Global Action Plan on AMR in 2015 aan populariteit wint, werd ontwikkeld. 
Ik analyseer de internationale beleidsdocumenten op het gebied van AMR en het internationale 
gezondheidsbeleid  waarvan AMR-documenten zijn afgeleid, en bekijk hoe de One Health-
aanpak voor AMR in deze documenten wordt vormgegeven.  Beleidsdocumenten worden hier 
opgevat als performatief – ze beschrijven niet alleen de realiteit over AMR maar ze construeren 
deze realiteit en ook de handelingspersdpectieven van betrokkenen uit de gezondheidszorg, de 
veeteelt en de milieusector. Het hoofdstuk gebruikt theorieën van het post-humanisme om de 
relaties tussen deze sectoren in de One Health-benadering van AMR kritisch te onderzoeken.   
De analyse laat zien dat de One Health-benadering voor de aanpak van AMR, ondanks de 
doelstelling om intersectoraal te werken, impliciet hiërarchieën creëert tussen de gezondheid 
van mensen, dieren en ecosystemen, en ook tussen professionals die in deze domeinen werken. 
De gezondheid van mensen wordt als het meest centrale probleem gezien, en de andere sectoren 
moeten bijdragen aan de oplossing ervan. De gezondheid van dieren, gedomesticeerd en wild, 
en van het ruimere milieu verschijnt onbedoeld  als ondergeschikt aan dat van mensen.   
Hoofdstuk 2 verschuift de focus van de beleidsarena naar de volksgezondheid, en 





vluchtelingen crisis leidt  in 2015 zichtbaar in Europa tot discussies over nut en dilemma’s van 
AMR-screening van vluchtelingen. Tegen de achtergrond van deze discussies heb ik 
verschillende perspectieven op de mogelijke constructie van vluchtelingen als een 
gezondheidsrisico onderzocht. Ik heb interviews gedaan met microbiologen, 
volksgezondheidsartsen, verpleegkundigen en vluchtelingen, en het blijkt dat AMR-screening 
vanuit hun perspectieven een verschillende betekenis krijgt.  Microbiologen en artsen 
werkzaam in de publieke gezondheidszorg zien screening als een noodzakelijke maatregel in 
het kader van het onderzoek naar de volksgezondheid, verpleegkundigen zien het als een 
onnodige stigmatiserende interventie die weinig bijdraagt aan de volksgezondheid, en veel 
vluchtelingen zien screening als een potentiele techniek voor verbetering van de persoonlijke 
gezondheid en als er geen individuele uitslagen worden gegeven zien zij het over 
stigmatiserend. Terwijl de debatten over de noodzaak van AMR-screening van vluchtelingen 
primair een debat was van microbiologen in wetenschappelijke tijdschriften, heb ik geprobeerd 
de actoren te onderzoeken die er in de praktijk mee te maken zouden kunnen krijgen. Het 
hoofdstuk pleit voor meer samenwerking bij de ontwikkeling en implementatie van de 
screening, waarbij volksgezondheidsrisico’s en risico's van stigmatisering beide worden 
gewogen. 
In hoofdstuk 3 gaat de reis verder naar de wereld van de gezondheidszorg, en wel de 
gezondheidszorg in Rusland. Rusland is een interessante setting omdat recentelijk maatregelen 
zijn getroffen om wetgeving die antibiotica gebruik zonder doktersvoorschrift tegen moet gaan, 
te gaan implementeren en handhaven. Tot voor kort konden mensen antibiotica bij de apotheker 
halen: aan deze vorm van ‘zelfmedicatie’ moet nu een einde komen. We hebben interviews 
gedaan met artsen, apothekers en patiënten om te onderzoeken hoe zij omgaan met deze eis 
van antibioticagebruik op medisch voorschrift. De analyse geeft een reflectieve blik op de 
organisatie van antibioticagebruik en zorg voor bacteriële infecties in Rusland. De zogenaamde 
zelfmedicatie met antibiotica moet begrepen worden in de specifiek Russische context die 
gekarakteriseerd wordt door gebrek aan medisch personeel in de klinische setting,  lange 
wachttijden, de gebrekkige mogelijkheden van veel patiënten om vrijaf te nemen en dus 
inkomen te derven om een arts te bezoeken. Omdat iedereen dit weet en artsen toch ‘goede 
zorg’ willen leveren, ontstaan er informele infrastructurele antibiotica praktijken om ‘’het 
verplichte recept’’ werkbaar te maken. Dokters schrijven recepten voor een langere duur, voor 
het geval dat de klachten verergeren, of een hogere dosis zodat patiënten vooruit kunnen. Deze 





Hoofdstuk 4 analyseert metaforen die microbiologen gebruiken om hun wetenschappelijk 
onderzoek over AMR en reizen te presenteren.  Metaforen zijn interessant omdat ze geen 
onschuldige beeldspraken zijn, maar verbeeldingen van de realiteit en als zodanig een basis om 
te handelen. Metaforen geven als theoretische concepten richting aan wetenschappelijk 
onderzoek, ook aan disciplines die het imago hebben dat ze ‘’de natuur’’ representeren. Ook 
in deze disciplines speelt taal echter een sleutelrol in de verbeelding van onderzoeksresultaten. 
Voor de analyse heb ik een specifieke set belangrijke wetenschappelijke artikelen van 
microbiologen onder de loep genomen. De analyse laat zien dat onderzoekers met behulp van 
metaforen als AMR ‘reservoirs’ en bacteriële ‘indringers’, de overdracht van AMR op 
wereldschaal schetsen als een proces waar gevaarlijke bacteriën uit lage-inkomenslanden 
worden overgedragen aan landen met een hoog inkomen met een ‘betere hygiëne. Hiermee 
worden landen impliciet als ‘goed’ en ‘slecht’ voorgesteld. Het beschrijven van bepaalde 
landen als AMR-reservoirs en andere landen als landen met een betere hygiëne, leidt er toe dat 
de overdracht van AMR van inkomende reizigers naar deze landen-reservoirs minder aandacht 
krijgt. Ook worden landen als homogene entiteiten voorgesteld terwijl grensgebieden 
bijvoorbeeld vaak andere patronen laten zien. De conclusie luidt dat het belangrijk is om te 
reflecteren op metaforisch gebruik van kernconcepten in AMR onderzoek en wat zij doen in 
beeldvorming en in de verdere ontwikkeling van onderzoek, omdat ze impliciet sommige zaken 
naar de voorgrond en de achtergrond duwen.   
Als onderzoeksteam zijn we overtuigd van de waarde van transdisciplinair onderzoek naar 
AMR. Hoofdstuk 5 beschrijft het gebruik van een experimentele transdisciplinaire 
methodologie ‘stool and stories’ die we hebben ontwikkeld om AMR te bestuderen als een bio-
sociaal fenomeen. Dit hoofdstuk presenteert de microbiologische analyse van 
ontlastingsmonsters en de sociologische analyse van semi-gestructureerde interviews, beide 
uitgevoerd binnen een cohort van studenten die de Global Health master volgden en uit 
verschillende delen van de wereld naar India reisden voor een symposium. De twee 
verschillende datasets richten zich op dezelfde onderzoeksvraag over het belang van AMR voor 
internationale reizen, maar geven verschillende antwoorden op deze vraag. Terwijl de 
microbiologische analyse (stool) laat zien hoe internationaal reizen samenhangt met het 
verwerven van AMR, toont de sociale wetenschappelijke analyse (stories) dat reizigers zelf 
AMR niet als een relevant gezondheidsrisico van reizen beschouwen. Dit verschil wijst erop 
dat de biologische en sociale constructies van AMR – ook in een cohort van hoogopgeleide en 





conclusie is dat het voor een beter begrip van AMR en AMR-preventie noodzakelijk is 
dergelijke verschillende resultaten met elkaar in dialoog te brengen.    
Hoofdstuk 6 is een korte reflectie op mijn promotietraject als een transdisciplinair 
onderzoek. Deze reflectie pleit voor infrastructurele veranderingen in de huidige organisatie 
van het AMR-onderzoek, waarbij biomedische en sociaalwetenschappelijke benaderingen van 
AMR sterk gescheiden zijn. In plaats daarvan moeten er transdisciplinaire 
samenwerkingsplatforms, wetenschappelijke tijdschriften, conferenties, en 
financieringsvormen gecreëerd worden op nationaal en internationaal niveau, om AMR te 
begrijpen.  
Discussie en conclusie. De zes hoofdstukken van dit proefschrift laten zien dat AMR niet 
een ding is, maar in verschillende contexten als een ander fenomeen wordt geconstrueerd, en 
op verschillende manieren wordt behandeld: de aanpak van AMR wordt uitgedrukt in termen 
van hiërarchieën tussen soorten, sectoren en disciplines, risico’s voor gezondheid en voor 
stigmatisering, relaties tussen gezonde en riskante werelddelen. Op basis van mijn onderzoek 
stel ik voor om meer aandacht te besteden aan de politiek, economische en sociale 
infrastructuren die door AMR in het leven zijn geroepen. Een transdisciplinaire benadering is 
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